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Pregnancies conceived through assisted reproductive technologies (ART) are 
increasing in prevalence in maternity units in Ireland due to the increasing numbers 
of women attending for ART. This is due in a large part to the increasing age profile 
of women attempting to conceive for the first time but also due to the increasing 
success of ART itself  (1).   
The advent of ART and the increasing numbers of pregnancies resulting from 
ART also brought an increase in the numbers of multiple pregnancies. Multiple 
pregnancy has been shown to carry a higher rate of preterm delivery than singleton 
pregnancy and a higher rate of adverse obstetric and perinatal outcomes. This led to 
many governing bodies, including the Human Fertilisation and Embryology Authority  
(HFEA) in the UK and the American Society for Reproductive Medicine  (ASRM) in USA 
calling for a reduction in the number of embryos being transferred in order to reduce 
the numbers of multiple pregnancies from ART  (2). Elective single embryo transfer  
(eSET) is advised in good prognosis patients- women under the age of 35 - 37 with 
more than one good quality blastocyst available for transfer  (3). Although livebirth 
rates are lower in eSET versus double embryo transfer (DET) cycles, the risk of 
multiple pregnancy and its associated complications is lower. Furthermore, several 
studies, including a Cochrane Database System Review, have demonstrated that 
when cumulative livebirth rates of an unsuccessful eSET cycle followed by a 
subsequent frozen-thawed embryo are compared to a DET cycle they are 
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comparable, with a significantly reduced risk of multiple pregnancy  (4). We wished 
to investigate if there were identifying factors which would allow a more 
individualised approach to selecting the number of embryos for transfer according 
to obstetric risk factors, particularly pre-term labour. 
The original hypothesis of the thesis was that, due to the increased risk of 
preterm labour associated with multiple pregnancies, if a woman could be identified 
prior to in vitro fertilisation (IVF)/ intracytoplasmic sperm injection (IVF/ICSI) 
treatment as being at high risk of preterm labour then she should have a single 
embryo transfer. Conversely, if a woman was deemed low risk for preterm labour 
than it may be more reasonable to consider a double embryo transfer, allowing for a 
more individualised embryo transfer policy tailored to the risk profile of the woman.  
Nulliparous women were selected for inclusion. Exclusion criteria were; 
multiparty, previous preterm delivery  (spontaneous delivery prior to 37 weeks 
gestation) or late miscarriage  (pregnancy loss between 12+1 and 23+6 weeks 
gestation), a history of cervical excisional surgery  (Large Loop Excision of the 
Transformation Zone  (LLETZ) or knife conisation), pre-existing serious maternal 
medical disorders that may increase risk of pre-term delivery  (e.g. essential 
hypertension, poorly controlled diabetes, epilepsy), the use of confounding 
treatment  (e.g. elective cervical suture placement). The rationale for these exclusion 
criteria was to ensure that there was no pre-existing risk of spontaneous (cervical 
excisional surgery, late miscarriage) or iatrogenic (serious maternal co-morbidities) 
preterm delivery amongst the recruited cohort. One of the factors studied in the 
recruited cohort was the volume and dimensions of the uterus immediately prior to 
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commencing Follicle Stimulating Hormone (FSH) stimulation in an IVF/ICSI cycle. This 
was performed with both 2-dimensional (2D) and 3-dimensional (3D) ultrasound to 
assess if these measurements would inform pre-term labour risk, particularly in twin 
pregnancies. 
An interim assessment identified that the number of twin pregnancies 
occurring in the recruited cohort was too low to adequately power the prospective 
cohort study (detailed in Chapter Three) and adequately test our hypothesis. 
Furthermore, the retrospective study, detailed in Chapter Two, which examined the 
obstetric and perinatal outcomes of twin pregnancies conceived through IVF/ICSI and 
compared them to spontaneously conceived twins, demonstrated that ART 
conceived twins had reasonable perinatal outcomes with only a slightly higher rate 
of moderate preterm delivery and a very low rate of extreme prematurity. The 
retrospective study demonstrated that, with improvements in obstetric and perinatal 
care including dedicated twin clinics with appropriate ultrasound monitoring, twin 
pregnancies, irrespective of mode of conception have reasonably favourable 
outcomes. These findings were published in a peer reviewed article ‘Obstetric and 
perinatal outcomes of twin pregnancies conceived following IVF/ICSI treatment 
compared with spontaneously conceived twin pregnancies’  (5). 
It also recognises that singleton pregnancies are a significantly lower risk 
pregnancy and therefore the regulation over the numbers of embryos transferred is 
important, in order to achieve a low rate of twin pregnancies. The elective single 
embryo transfer policy that was being increasingly employed by Cork Fertility Centre 
during the years of recruitment resulted in a lower twin pregnancy rate than 
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expected. In view of these findings the scope of the thesis was expanded to include 
singleton pregnancy outcome and to examine multiple other factors, including stress, 
lifestyle factors, demographics and biochemistry in the wider ART population, that 
may impact on treatment cycle and pregnancy outcome after IVF/ICSI.  
 
Retrospective study (Chapter 2) 
Chapter two details the retrospective study of the pregnancy outcomes of 
singleton and twin pregnancies conceived following ART. The twin pregnancy cohort 
was compared to a cohort of spontaneously conceived twins (6). Dichorionic 
diamniotic twins were specifically selected as these twins result from the transfer of 
two embryos (iatrogenic twinning) and therefore could have been avoided if a single 
embryo was transferred. This represents an option for intervention should certain 
women be identified as having an increased risk of adverse twin pregnancy outcome 
following ART. The study found that ART conceived twins had a high livebirth rate, of 
291 ART conceived twin pregnancies 86.8% resulted in a livebirth of one or both 
twins. ART conceived twins had similar obstetric and perinatal outcomes to 
spontaneously conceived twins. There was no difference in the rates of preterm 
delivery between the groups and there was a very low rate of extreme prematurity 
that did not differ between the groups. Overall, perinatal outcomes were similar.  
The outcome of singletons conceived from IVF/ICSI was also retrospectively 
studied. Unfortunately, it was not possible to have a matched spontaneously 
conceived cohort of singleton pregnancies. Overall, singleton outcomes (n = 1790) 
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were very favourable with a high livebirth rate (80%) and a high term delivery rate 
(93%).  
Vanishing twin syndrome (VTS) singletons were also analysed for outcome. 
VTS singleton outcomes were compared with singleton outcomes. There was no 
significant difference in gestation at delivery between the two groups. However, VTS 
singletons were significantly more likely to be delivered by emergency caesarean 
section (24% v 15%). 
Pregnancy outcomes of singleton pregnancies versus twin pregnancy were 
analysed. Singleton pregnancies were more likely to result in a livebirth while twin 
pregnancies were almost twice as likely to result in miscarriage of one or both twins. 
Twins were four times more likely to be delivered before 36 weeks gestation than 
singletons. Twins are three times more likely to be admitted to the Neonatal Unit 
(NNU) than singletons. 
These results demonstrate that the mode of conception of a twin pregnancy 
does not incur a significantly higher obstetric or perinatal risk. However twin 
pregnancy itself has a higher rate of adverse outcomes when compared to singleton 
pregnancy. Furthermore, VTS singletons (pregnancies that began as twins) 
demonstrated a significantly higher rate of caesarean delivery. These findings further 





Prospective Cohort Study (Chapter Three) 
Chapter three details the findings of the prospective cohort study of 
nulliparous women attending Cork Fertility Centre at the outset of their IVF/ICSI 
cycle. The recruited women underwent both a 2D and 3D ultrasound of the uterus 
immediately prior to commencing FSH stimulation. Women were also invited to 
complete a detailed survey on lifestyle and demographics. The initial aim of the study 
was to analyse the outcomes of twin pregnancies conceived by IVF/ICSI, however, an 
interim assessment recognised that the number of twin pregnancies in the recruited 
cohort was too low to adequately power the study and it was therefore expanded to 
include singleton pregnancy outcomes. The low rate of twin pregnancy numbers was 
as a result of logistical issues limiting recruitment and the recent adoption of a 
successful eSET programme in the clinic, resulting in a lower twin pregnancy rate. 
The women were prospectively followed up to analyse the occurrence of 
pregnancy, or not, and any factors that may influence conception rates. All ongoing 
pregnancies were analysed for the occurrence of obstetric complications, including 
gestational diabetes, pregnancy induced hypertension and pre-eclampsia. 
One hundred and forty- two women were recruited for this study according 
to the inclusion criteria. None of the interrogated demographics or lifestyle factors 
(including smoking, alcohol intake and BMI) demonstrated a significant impact on the 
rate of conception nor on the rate of pregnancy loss. Neither uterine length nor 
volume impacted on pregnancy rates from IVF/ICSI or on preterm delivery rates. 
Overall, the rate of preterm delivery was 19% with only one very preterm delivery 
and no extreme preterm deliveries. Women with a higher antral follicle count had a 
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four-fold increased chance of livebirth compared with women with a reduced antral 
follicle count.  
 
Cross-Sectional Study (Chapter Four) 
Chapter four details the findings of the cross-sectional study which was a 
survey-based study assessing the impact of demographics, lifestyle and psychological 
factors on ART outcome. There is evidence in the medical literature to suggest that 
high perceived stress in early pregnancy is associated with increased rates of 
miscarriage  (7).   
The aim of this study was to determine if psychological stressors have an 
impact on IVF/ICSI treatment cycle outcomes including miscarriage rates. A survey-
based study of 320 women recruited prior to commencing IVF/ICSI treatment and 
followed prospectively for treatment outcome (negative/positive pregnancy test, 
first trimester miscarriage). The survey focused on perceived stress, emotional well-
being, maternal social support and outlook. The women were asked to grade their 
responses according to a specified scale. 290 (90%) women proceeded to ART 
treatment of which 58% conceived. Analysis of individual life stressors in the 
preceding 12 months, including job stress or serious financial problems did not reveal 
significance in terms of conception. A small number had experienced serious illness 




The women were further analysed according to livebirth and pregnancy loss 
(biochemical pregnancy and miscarriage). Individual life stressors revealed a 
significantly higher rate of pregnancy loss amongst those who reported a 
stressful/demanding job. The findings suggest that stressors do not impact greatly on 
conception rates from ART but may negatively impact on miscarriage rates. Job-
related stress, in particular, is associated with higher chance of miscarriage. This 
suggests that there may be a role for stress management in early pregnancy.  
During ART there is an element of control over the number of embryos being 
transferred and the resultant rate of twin pregnancy. Therefore, in the absence of 
any robust predictors of successful, or indeed adverse, outcome it is preferable to 
aim for single embryo transfer and a singleton pregnancy.  Couples with two good 
quality embryos should be counselled regarding the increased risk of iatrogenic 
twinning and its implications, associated with double embryo transfer. The thesis 






































The World Health Organisation  (WHO) defines infertility as a disease of the 
reproductive system defined by the failure to achieve a clinical pregnancy after 12 
months, or more, of unprotected sexual intercourse  (8). 
Approximately 1 in 7 couples will experience fertility problems during their 
reproductive lives. In recent years, there has been a steady increase (5 - 10% per 
annum) in the number of couples attending for fertility treatment. In Ireland, the age 
of women at the time first pregnancy is increasing, reflecting societal and economic 
factors resulting in women delaying childbearing until the third decade (9). The 
corollary of this is an increasing number of couples struggling to conceive. 
There are several aetiologies of subfertility that may be attributed to the 
female partner, the male partner or both partners. Unexplained subfertility is the 
most frequently occurring aetiology (25%), where there is no identifiable cause for 
the couple’s inability to conceive. Male factor subfertility is due to abnormalities of 
sperm production or ejaculation and accounts for a further 30% of aetiologies. 
Female factors account for another 30% and include diminished ovarian reserve, 
tubal factors and endometriosis  (10). 
Assisted reproductive technologies (ART) were first examined in the mid 
1800’s when artificial insemination was first performed by Dr. Marion Sims at The 
Women’s Hospital, New York. The area of in vitro fertilisation was explored in the 
early 1900’s, initially with Harvard scientist Gregory Pincus’ work with rabbits which 
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was advanced by John Rock and Miriam Menkin who, in 1944, achieved in vitro 
fertilisation of a human oocyte by human spermatozoa. 
Scientists internationally continued in attempts to perfect in vitro 
fertilisation, including Robert Edwards, who travelled to John Hopkin’s University 
Hospital for a six-week fellowship, where he finally achieved successful fertilisation 
of a human egg. Robert Edwards then met Patrick Steptoe in London and continued 
in his pursuit to implant a fertilized oocyte into a female uterus. Ultimately, they 
become the first scientists to achieve a successful pregnancy, resulting in the first live 
birth of a “test tube baby” Louise Brown in 1978. Australia and USA quickly followed 
with live births in 1980 and 1981 respectively, heralding the beginning of IVF success 
internationally. 
IVF and other forms of ART have continued to develop in technique and 
popularity with more than 350,000 babies born annually from IVF/ICSI treatment 
worldwide. The International Committee for Monitoring ART (ICMART) most recently 
reported on the triennia 2008 - 2010. During this period, there were 4,461,309 cycles 
initiated, resulting in the birth of approximately 1,144, 858 babies (11). Societal 
changes, particularly in the role of women, has resulted in and increasing number of 
women delaying childbearing and ultimately requiring ART to achieve a pregnancy.  
Access to ART is variable with some countries, such as the UK, providing state-
funded treatment options for couples. Other countries provide only very limited/no 
state funding for ART, requiring the couples to self-fund treatment (12, 13). In 
Ireland, where there is no state funding for ART (although the medication costs are 
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funded) ART is solely provided by private clinics with the average IVF cycle costing a 
couple approximately €4,000 or more.  
 
1.1 What are assisted reproductive technologies? 
 
Assisted reproductive technologies (ART) comprise of a range of medical 
treatments involving the application of laboratory or clinical technology to human 
gametes and/or embryos in order to achieve pregnancy in a subfertile couple.  
 
1.1.1 Intra-uterine insemination 
Intrauterine insemination (IUI) is frequently the first line treatment option for 
those couples with unexplained subfertility. The pre-requisite to IUI is patent 
Fallopian tubes and a suitably prepared sperm sample. IUI can be carried out in a 
natural cycle or with controlled ovarian stimulation (COH). Superovulation with 
gonadotrophins (Follicle Stimulating Hormone; FSH) results in the development of 1 
- 2 dominant follicles, the development of which is monitored by transvaginal 
ultrasonography. Once the dominant follicle is at least 18mm in size ovulation is 
triggered with human Chorionic Gonadotrophin (hCG). Insemination of a prepared 
sperm sample into the uterine cavity is performed the following day. IUI/COH results 
in a per cycle pregnancy rate ranging between 11 - 16.4%  (14-17). 
IUI has the benefit of occurring within the timeframe of a natural menstrual 
cycle, is less invasive - requiring only catheterisation of the uterus to deposit the 
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sperm sample, and less costly than IVF treatment. However, the success rates are 
lower and there is concern regarding the higher multiple pregnancy rates associated 
with IUI. To this end, in 2013 the National Institute for Health and Care Excellence 
updated the guidance on IUI/COH, advising that IUI should no longer be offered to 
couples with a diagnosis of unexplained subfertility. Such couples should be advised 
two years of expectant management before proceeding directly to IVF  (18). This 
guidance is based on low- to very low-quality evidence indicating that treatment with 
IUI  (with or without COH) shows no significant increase in live birth over expectant 
management  (19, 20). One of the concerns of the NICE guideline development group 
is the high rate of multiple pregnancies with IUI/COH and the lack of control over the 
occurrence of multiple pregnancies when compared with IVF and single embryo 
transfer. This is a valid concern to address given the well-documented increased 
perinatal risk of multiple pregnancies  (21, 22).  Patients who have not achieved a live 
birth with IUI treatment generally move on to IVF treatment which carries higher 
success rates but is more expensive and invasive than IUI. 
 
1.1.2 In vitro fertilisation 
In vitro fertilisation (IVF) was originally developed to overcome bilateral tubal 
occlusion. Today, IVF is used for a variety of aetiologies of subfertility- failure to 
conceive from IUI, diminished ovarian reserve, endometriosis, moderate sperm 
dysfunction. The number of cycles of IVF continues to increase with the Human 
Fertilisation and Embryology Authority showing a near 5% year on year increase in 
the number of IVF cycles undertaken in the UK alone  (23). 
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Current ART practice involves ovarian superovulation with gonadotrophin - 
releasing hormone (GnRH) analogues, most frequently FSH alone, or in combination 
with luteinising hormone (LH). Once the lead follicle is at least 18mm in size and there 
are at least three follicles greater than 17mm ovulation is triggered with hCG or a 
GnRH agonist. Thirty-six hours following the administration of ovulatory medications, 
oocyte retrieval is performed. This typically involves transvaginal ultrasound-guided 
needle-aspiration of follicular fluid and retrieval of mature oocytes from this fluid. 
The oocytes are then inseminated with a prepared sperm sample (requiring a sperm 
count of > 500,000 motile sperm to be suitable for IVF) and fertilisation is awaited. 
Fertilisation is identified 18 - 24 hours later by the presence of two pronuclei in the 
fertilised oocyte. 
Standard IVF requires the presence of more than 500,000 motile sperm in the 
total ejaculate. Intracytoplasmic sperm injection (ICSI) is adopted in situations where 
there is severe sperm dysfunction. In this situation, the cytoplasm of each mature 
oocyte is injected with a single spermatozoon and the fertilisation rate is assessed 18 
hours later. ICSI may also be considered where fertilisation has failed with IVF despite 
normal sperm preparation. 
On day 3 following oocyte retrieval the resultant embryos are assessed for 
grading based on their morphological appearance. Embryo transfer typically occurs 
on day 3 or day 5 (usually between 2 - 5 days), following oocyte retrieval. The decision 
for embryo transfer depends on the quantity of good-quality oocytes. Embryo quality 
is based on the morphological appearance of the embryo according to the 
developmental stage. If the numbers and quality of embryos are deemed sufficient 
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then embryo culture will be continued to blastocyst stage (day 5 post oocyte 
retrieval). At this stage, the superior quality blastocyst (s), based on morphological 
appearance, are selected for transfer into the uterus. Day five, or blastocyst, transfer 
has been shown to have a positive effect on pregnancy rates  (24).  Luteal phase 
support is typically with vaginal or parenteral progesterone and /or hCG. Pregnancy 
testing by detection of urinary hCG or serum βhCG is usually performed 18 days 
following oocyte retrieval 
 
1.2 Recent developments in ART 
 
1.2.1 Gamete donation 
Gamete donation is most frequently sperm donation for couples where the 
male partner has azoospermia. More recently, sperm donation is being used by single 
women and homosexual women to achieve pregnancy. Donor sperm can be used for 
intrauterine insemination or IVF/ICSI. Oocyte donation, since its introduction 30 
years ago, has become an increasingly common solution to involuntary childlessness. 
The oocyte donor undergoes superovulation and oocyte retrieval and the retrieved 
oocytes are fertilized (with IVF or ICSI) with the male partner’s (or donor) sperm.  
Initially, it was used to enable women with premature ovarian failure to conceive  
(25). Increasingly, it is recommended to women of advanced reproductive age and 
to those with intractably poor embryo quality  (26). The most recent European data 
from 34 countries, reported 25,187 egg donation cycles  representing a 16.6% 





Cryopreservation of both gametes and embryos has become more successful 
in the past 5 years since the introduction of vitrification  (29, 30). 
Sperm cryopreservation has been used for many years at sperm banks for 
donor sperm and following surgical sperm retrieval in men with oligozoospermia.   
The main indication for oocyte cryopreservation is fertility preservation prior 
to chemotherapy or radiotherapy. Increasingly, oocyte cryopreservation is now being 
used by women for social reasons, i.e. fertility preservation until socially the time is 
right to pursue pregnancy e.g. after establishment of her career or delay in meeting 
a suitable male partner. Oocyte cryopreservation has limitations in terms of 
safeguarding fertility  (31). The most recent report from the Human Fertilisation and 
Embryology Authority  (HFEA) in the UK for the first time contained data on oocyte 
cryopreservation  (23). It reported a 25 - 30% year on year rise in the number of 
women undertaking oocyte cryopreservation, with 102 cycles of IVF in 2013 (rising 
to 129 cycles in 2014) using cryopreserved oocytes, yielding only a 14% pregnancy 
rate (compared with an average 26% success rate for IVF with fresh oocytes).  
Embryo cryopreservation is becoming increasingly successful due to the more 
widespread use of a recent cryopreservation method known as vitrification. There is 
some evidence that a frozen - embryo transfer (FET) may result in improved 
pregnancy rates when compared to a fresh embryo transfer   (31). 
Vitrification involves an extremely high cooling rate (15,000 oC to 30,000 
oC/minute). High concentrations of cryoprotectant are used to prevent ice crystal 
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formation.  This rapidly dehydrates the cells and rapid submersion into liquid 
nitrogen avoids the development of the large intracellular or extracellular ice crystals 
that can be damaging to the cells during the freeze/thaw process. Slow freezing is 
more time-consuming and less effective at avoiding ice crystal formation due to the 
use of a lower concentration of cryoprotectant. Vitrification has also proven an 
indispensable technique in developing advanced technologies pre-implantations 
genetic diagnosis/screening (PGD/PGS). Due to high survival rates and low rates of 
cooling injury, cryopreservation by vitrification has greatly improved the survival rate 
of biopsied embryos and giving a greater flexibility to PGD cycles  (32). 
 
1.2.3 Pre-implantation genetic diagnosis and screening 
Pre-implantation genetic diagnosis  (PGD) was first described in the medical 
literature in 1990  (33, 34). Since its introduction twenty years ago, PGD has grown 
steadily with new applications and methodology introduced regularly, becoming an 
established and accessible alternative to invasive prenatal diagnostic tests for many 
couples with specific inherited disorders. These may be single gene disorders or 
chromosome rearrangements. Single gene disorders may be inherited in an 
autosomal dominant pattern  (Huntington’s disease, myotonic dystrophy type 1, 
neurofibromatosis), autosomal recessive  (Cystic fibrosis (CF), spinal muscular 
atrophy) or X-linked pattern  (haemophilia, Fragile X)  (35). In Ireland, the first live 
birth following PGD was in 2014. PGD was performed due to the male partner, 
affected by CF, being homozygous for Δf508 mutation and the female partner being 
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a known CF carrier  (G551D mutation) giving the couple a 50% chance of a child 
affected by CF  (36). 
Pre-implantation genetic screening (PGS) is a more recent development, 
utilising array - comparative-genomic hybridisation (array-CGH), or more recently, 
next generation sequencing (NGS) in order to assess the chromosomal complement 
of the embryo for aneuploidy. The initial drive for PGS was to improve general IVF 
success rates. This was due to situations where morphologically good quality 
embryos were implanted but did not result in live births. The theory evolved that in 
spite of top quality grading based on morphology and development an embryo may 
be aneuploid and therefore less likely to implant and/or more likely to result in 
miscarriage  (37). PGS has found other potential applications in cases of recurrent 
implantation failure, recurrent pregnancy loss and IVF in cases of advanced maternal 
age (associated with a higher risk of aneuploidy).  PGS has been shown not to increase 
the live birth rate but to decrease the number of embryo transfers (by avoiding 
transfer for aneuploid embryos) and therefore, decrease the time to a successful live 
birth. The European Society of Human Reproduction and Embryology  (ESHRE) PGD 
Consortium 2010 reported that 5,780 oocyte retrievals had been performed in 62 







1.3 How successful is ART? 
 
Advances in the treatment process over the past 20 years have led to a steady 
increase in pregnancy and live birth rates. The Human Fertilisation and Embryology 
Authority  (HFEA) in UK reported an increase in live birth rate from 14% in 1991 to 
25% in 2011  (39). In Ireland, Naasan et al reported on ten years of ART data from 
Irish fertility clinics, demonstrating an increase in clinical pregnancy rates per cycle 
from 22.9% per oocyte retrieval in 1999 to 29.8% per oocyte retrieval in 2008  (see 
Table 1.1 and Table 1.2)  (40). During that time period there was a substantial 
increase in the number of fertility clinics in the country, correlating with an almost 
three- fold increase in the number of IVF cycles. More recent data from ART in Europe 
ESHRE reports shows a drop in the number of fertility clinics choosing to report to 
ESHRE. However, there is an increase in the livebirth rate after IVF/ICSI treatment 
here, likely corresponding to better laboratory techniques. There is an increase in the 
livebirth rate from frozen embryo transfer (FET) which likely corresponds to the 














Table 1.1: Ten years of national Irish ART data 






IVF1 ICSI2 FET3 OD4 All cycles 
1999 5 3 689 472 177 0 1338 
2000 5 3 782 527 261 0 1570 
2001 5 3 917 569 238 0 1724 
2002 5 5 952 567 390 3 1912 
2003 5 4 1078 618 359 3 2058 
2004 5 6 1267 847 466 0 2580 
2005 7 6 1429 901 524 6 2860 
2006 7 6 1588 1004 636 4 3232 
2007 7 6 1768 1096 692 9 3556 
2008 7 5 1772 1094 682 9 3548 
2009 7 6 1987 1328 744 6 4065 
2010 7 6 1856 1320 882 20 4078 
2011 7 5 1200 1080 762 0 3042 
2012 7 4 1119 1008 706 0 2843 
2013 7 3 678 517 371 0 1566 
2014 7 3 623 505 385 0 1513 
 
Data extracted from Naasan et al. Assisted reproductive technology treatment 
outcomes. Irish medical journal. 2012 May;105 (5):136 - 9  (40) and from ART in 
Europe, 2009, 2010, 2011, 2012, 2013 and 2014: Results generated from European 
Registers by ESHRE 
1- IVF- in vitro fertilisation 
2- ICSI- intracytoplasmic sperm injection 
3- FET- frozen embryo transfer 




Figure 1.1: Ten years of Irish ART data in a graph. 
Data extracted from Naasan et al. Assisted reproductive technology treatment 
outcomes. Irish medical journal. 2012 May;105 (5):136 - 9  (40) and from ART in 
Europe, 2009, 2010, 2011, 2012, 2013 and 2014: Results generated from European 
Registers by ESHRE 
 
 
Table 1.2: Deliveries following IVF, ICSI and Frozen embryo transfer (FET) in Ireland 



























2009 6 1599 22.6 1137 23.1 744 15.3 
2010 6 1483 25.6 1173 
26.1 
882 13.9 
2011 5 1035 24.7 1003 21.5 762 16.3 
2012 4 904 24.7 922 24.4 716 14.1 
2013 3 519 33.9 498 26.5 371 20.8 
2014 3 507 34.9 460 33.5 385 20.8 
1 EC = egg collection 
Data extracted from ART in Europe, 2009, 2010, 2011, 2012, 2013 and 2014: Results 
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Figure 1.2: Number of egg collections (EC) for IVF or ICSI and number of embryo thawing’s 
for Frozen embryo transfer (FET) in Ireland 2009 - 2014. 
Data extracted from ART in Europe, 2009, 2010, 2011, 2012, 2013 and 2014: Results 







Figure 1.3: Deliveries per egg collection following IVF or ICSI and per Frozen embryo transfer 
(FET) in Ireland 2009 - 2014. 
Data extracted from ART in Europe, 2009, 2010, 2011, 2012, 2013 and 2014: Results 
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1.4 Factors influencing successful outcome of ART 
 
1.4.1 Age 
The age of the female partner is one of the more significant determinants of 
ART success. In females, during fetal development, a finite number of germ-line 
oogonia are formed, the number of oocytes is at a maximum at 20 weeks gestation 
(6 - 7 million), decreasing to 1 - 2 million at birth. They remain as primordial follicles 
until completion of the process of meiosis, just prior to ovulation. Importantly, no 
new oocytes are formed during a woman’s reproductive life. Conversely, the 
primordial follicles are recruited daily from this pool until the age of menopause, 
resulting in the continuous attrition of the pool of follicles  (41). The rate of attrition 
increases with age  (diminishing ovarian reserve), doubling after approximately 37.5 
years, thus accelerating the decline in fertility and fecundity seen with advancing age  
(42). Furthermore, the quality of the remaining oocytes also diminishes with 
advancing age. 
Fertility declines precipitously after 37 years of age, however the slow decline 
starts much earlier, with recent studies suggesting that women aged 19 - 26 years 
have twice the chance of spontaneous pregnancy compared with women aged 35 - 
39 years  (43). Female age is one of the most significant determinants of ART success. 
IVF requires the retrieval of a number of mature oocytes to result in the development 
of an embryo of sufficient quality to achieve live birth. Therefore, the decline in 
oocyte numbers and quality seen in older women results in a corresponding decline 
in ART success in these women. The HFEA report of Fertility Treatment Trends and 
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Figures 2012 illustrates this age-related decline in live birth rate from IVF /ICSI 
treatment  (see Table 1.3)  (39). 
 




Table 1.3: Live birth rate (%) from IVF/ICSI treatment according to age range of women. 
Age range of women Live birth rate from IVF/ICSI 
Under 35 32.2% 
35 - 37 27.4% 
38 - 39 19.9% 
40 - 42 13.4% 
43 - 44 5.1% 
45 and over 0.8% 



















Age range of women
Live birth rate from IVF/ICSI
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1.4.2 Ovarian reserve  
Ovaries contain three populations of follicles: primordial (< 0.05mm in 
diameter), early growing (< 2mm in diameter) and antral follicles (> 2mm in 
diameter). It is the antral follicles that are highly sensitive to FSH. In the natural 
menstrual cycle, it is in the form of endogenous FSH, resulting in the development of 
a dominant follicle and the remainder of the antral follicles undergo atresia. In an IVF 
cycle it is in the form of high dose exogenous FSH resulting in stimulation of multiple 
follicles.  
The number of oocytes available for ovulation, i.e. the antral follicles (2 - 
10mm in diameter) are visible using transvaginal ultrasonography. The number of 
antral follicles (antral follicle count; AFC), reflects the number of remaining 
primordial follicles and therefore gives a good indication of ovarian reserve. AFC also 
gives an indication of the response to gonadotrophin stimulation and therefore an 
indication of oocyte yield at oocyte retrieval with subsequent impact on chance of 
live birth  (44). 
Serum FSH levels performed in the early follicular phase of the menstrual 
cycle (day 2 - 4) were the traditional biochemical test of ovarian reserve. High FSH 
levels (> 10 IU/L) may indicate a reduced ovarian reserve, with FSH > 15IU/L 
suggesting that the chance of ovulating a fertile oocyte are extremely low and FSH > 
25IU/L indicating menopause or premature ovarian insufficiency. Higher levels of FSH 
also indicate poor response to exogenous FSH stimulation and therefore a poor 
oocyte yield at oocyte retrieval. However, due to marked inter-cycle variability in FSH 
levels, a single measurement is not reliable in predicting ovarian reserve or response 
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to stimulation, particularly in women under 40 years of age. Indeed a woman with 
diminished ovarian reserve may not demonstrate an elevated FSH level  (45). 
Anti-Müllerian hormone (AMH) level has superseded FSH as a biochemical 
marker of ovarian reserve. AMH is produced by the pre-antral and antral follicles of 
the ovary and for that reason is indicative of a woman’s ovarian reserve. It does not 
display the inter- and intra- cycle variability of FSH and therefore a single 
measurement is more useful (Table 1.4). 
 
Table 1.4: Anti-Müllerian hormone level ranges and corresponding fertility potential.  
Fertility AMH level (pool/L) 
Very low/ undetectable  < 3.07 
Low  3.08-21.97 
Satisfactory 21.98 -40.03 
Optimal 40.04 - 67.9 
 
AMH has become a useful test in clinical practice as it has been shown to be 
predictive of ovarian response to stimulation. This is useful in predicting chances of 
successful outcome of IVF treatment in terms of oocyte yield but also in determining 
dose of gonadotrophin stimulation. In cases of very high AMH, often women with 
polycystic ovaries, it indicates a reduced dose of stimulation is required to avoid the 
risk of ovarian hyperstimulation syndrome  (OHSS), whereas a low AMH indicates 
diminished ovarian reserve  (DOR) and a requirement for an increased dose of 
gonadotrophins (46). Ovarian reserve declines with ovarian ageing, however this 
decline may not always correlate with increasing female age, i.e. a decline in ovarian 
reserve that is out of keeping with chronological age can be seen in younger women. 
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There is wide consensus in the medical literature regarding the effect of 
maternal age on fertility. Advancing male age however, is much less studied with less 
clear consensus on the role of advancing paternal age and fertility.  
Although it is known that men can father a child into their 7th and 8th decades 
of life, there is evidence of subtle changes in male fertility potential. Several studies 
have demonstrated a longer time to natural conception amongst older men, > 35 
years, when compared to younger men and controlled for maternal age  (43, 47-49). 
Semen parameters however, are not significantly affected by paternal age. A review 
by Dain et al showed agreement amongst four studies for a decline in semen volume 
and an associated decline in total sperm count and total motile sperm due to the 
reduced semen volume but no significant relationship between advancing age and 
sperm concentration, motility or morphology  (50). However, several other studies 
have found an effect of paternal age on sperm motility  (51-53). 
Maternal age significantly affects IVF/ICSI outcomes and for this reason it is 
difficult to clearly elucidate the possible effects of paternal age on ART outcomes. 
Several studies indicate an effect, when adjusted for maternal age, demonstrating a 
decline in live birth rates with advancing male age  (54-56). Interestingly, some 
studies reported on the combined effect of advanced maternal and paternal age 
resulting in lower pregnancy rates and raised the question regarding the ability of an 
older oocyte to repair DNA damage in older spermatozoa  (55). To this end, numerous 
groups have reported on the impact of paternal age in cycles using donor oocytes, as 
donor oocytes are generally from younger women. The results are mixed, further 
indicating the complex role of the female factor on ART outcome  (52, 57-60). 
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1.4.3 Body Mass Index 
Obesity has been identified as an important factor in general health. For 
women of reproductive age, it has important implications for pregnancy health, 
associated with gestational diabetes and intrapartum morbidity. In Ireland, the rates 
of obesity continue to rise, with almost one in five women now obese according to a 
study from a large tertiary maternity hospital  (61). 
The most commonly used measurement of weight is body mass index (BMI) 
measured as kg/m2 (see Table 1.5). 
 
Table 1.5: Body Mass Index (BMI) ranges. 
BMI category BMI Range (kg/m2) 
Underweight < 18.5 
Normal 18.5 - 24.9 
Overweight 25 - 29.9 
Obese Category I 30 - 34.9 
Obese category II 35 - 39.9 
Obese category III ≥ 40.0 
 
Women who are overweight or obese have lower spontaneous pregnancy rates 
compared with their normal weight counterparts  (62). Much of this discrepancy is 
linked to higher rates of polycystic ovarian syndrome amongst overweight and 
obese women with over one-third of with polycystic ovarian syndrome  (PCOS) 
obese, leading to alterations in the hypothalamic-pituitary axis and affecting 
40 
 
frequency and regularity of ovulation  (63). There exists significant debate however 
about the effects of overweight and obesity on success rates from IVF treatment. A 
systematic review of studies of overweight and obesity effect on IVF suggest the 
requirement for higher doses and longer duration of gonadotrophin stimulation, 
lower clinical pregnancy rates, higher miscarriage rates and reduced live birth rates 
amongst this population when compared to women of normal BMI  (64).  
Obesity has been shown to be a risk factor for poor obstetric outcomes, both 
maternal and fetal. These include gestational diabetes, gestational hypertensive 
disorders, increased rates of caesarean section, miscarriage, intrauterine fetal 
demise, fetal macrosomia and low birth weight. One study reported discrepancies in 
obstetric outcome according to mode of conception at normal and overweight BMI, 
with IVF-conceived pregnancies more likely to be complicated by placental ischaemic 
disorders and low birth weight.  Among the women in the obese category however, 
the risks of adverse outcome were not significantly different according to mode of 
conception, indicating that obese category BMI has a significant impact on pregnancy 
outcome irrespective of mode of conception  (65). 
Bodyweight plays an important role in the initiation of menarche and the 
maintenance of regular menstrual cycles. In order for puberty to progress normally 
a BMI of > 19 kg/m2 must be achieved and to maintain regular cycles a woman’s body 
should be comprised of at least 22% fat. Underweight also poses a risk to pregnancy 






Cigarette smoking has a detrimental effect on health and fertility. The 
metabolites of cigarette smoke cause oxidative damage to oocytes, sperm and 
embryos. Several studies have identified cigarette smoking as having negative effects 
on infertility and time to conception. A meta-analysis included 12 studies totalling 
10,928 female smokers and 19,179 female non-smokers found that smokers were 
significantly more likely to be infertile  (OR: 1.60, 95% CI: 1.34 – 1.91)  (67). 
Menopause occurs one to four years earlier in smoking women than in non-
smokers, likely secondary to acceleration of ovarian follicular depletion. Mean FSH 
levels are significantly higher in young smokers than in non- smokers. Luteal phase 
urinary oestrogen in smokers is only about one-third that observed in non- smokers. 
Current smoking is also associated with lower AMH levels in late reproductive age 
and perimenopausal women  (68). 
Mean gonadotropin dose requirements for smokers receiving stimulation for 




A varied diet is important for maintaining general health and a healthy BMI. 
A balanced diet supplies the nutrients necessary for activation of enzymes involved 
in DNA synthesis. Several of these enzymes are zinc- and vitamin B- dependent. 
Furthermore, a diet deficient in B vitamins- folate, B6 and B12- results in an increased 
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concentration of homocysteine. Hyperhomocysteinaemia has been shown to be 
detrimental to IVF/ICSI cycle success. Elevated levels in follicular fluid, aspirated at 
the time of oocyte retrieval, are negatively associated with oocyte numbers and 
embryo quality  (69, 70). 
Diets with high intake of fruit, vegetables, fish and vegetable oils are higher 
in folate, vitamin B6 and certain essential fatty acids e.g. linoleic acid (a pre-cursor 
for certain prostaglandins necessary for pre-antral follicle development and 
ovulation). Such diets are associated with improved IVF outcomes  (71, 72). Several 
studies also show a positive effect on sperm parameters, specifically progressive 
motility, in diets higher in fruit, vegetables and cereals  (73-76). 
This Mediterranean style diet is also a source of antioxidants- vitamin E, 
vitamin C, beta-carotene, folate and B vitamins- which reduce the amount of 
damaging reactive oxygen species (ROS). Micronutrients such as zinc, selenium, 
manganese, magnesium and copper also play a role, as co-factors of enzymes, in the 
antioxidant effect on ROS  (77). ROS are damaging to gametes and spermatozoa, in 
particular, are dependent on the antioxidants and DNA repair enzymes in seminal 
plasma for protection against ROS and the resultant sperm DNA fragmentation and 
membrane damage  (78). It is by mitigating against this damage that antioxidants are 
proposed to play a role in improving fertility. There remains no consensus however 
on the impact of sperm DNA fragmentation on IVF outcomes  (79, 80). 
Therefore, it is not surprising that there have been several studies into the 
benefits of antioxidant supplementation in males and females with mixed results. A 
Cochrane review of antioxidant supplementation in females found that the low to 
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very low-quality evidence demonstrated no improvement in live birth rate or clinical 
pregnancy rate. In three studies, pentoxifylline was the only antioxidant that 
demonstrated some evidence of a higher clinical pregnancy rate  (81). Antioxidant 
supplementation in males was also the subject of a Cochrane Review. Four 
randomised controlled trials (RCT) demonstrated a benefit in terms of live birth but 
the numbers in the studies were small and the quality of the evidence was deemed 
low. Similarly, seven low quality RCTs with small numbers suggested an increase in 
clinical pregnancy rate associated with male antioxidant supplementation  (82). 
Supplementation with folic acid for women of 400mcg daily in the 
preconception period and up to 12 weeks gestation has demonstrated a reduction in 
neural tube defects in the fetus  (83, 84). In men with severe oligozoospermia, there 
is some evidence for folic acid and zinc in combination in improving sperm 
concentration, although there is no consensus on the optimum dosage  (85). 
Vitamin D is the ‘wonder nutrient’ of our time and vitamin D deficiency has 
been implicated in a variety of medical conditions. Dietary vitamin D is found in such 
food sources as oily fish, egg yolks and fortified products (milk, cheese, orange juice). 
The other major source of vitamin D is sun exposure. Due to modern diet and indoor, 
sedentary lifestyle, there is an increasing prevalence of vitamin D insufficiency and 
deficiency. Of particular concern is the re-emergence of rickets due to the increasing 
prevalence of deficiency in pregnancy, particularly in ethnic minority groups.  
There have been several studies on the role of vitamin D in fertility, with two 
recent systematic reviews of the evidence  (86, 87). Vitamin D is a steroid hormone, 
the effects of which are mediated through the vitamin D receptor (VDR). These 
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receptors are found throughout the body. In females there are receptors in the 
ovaries and endometrium and in males in the epididymis, seminal vesicle, prostate 
and in the nucleus of spermatozoa.  
In the female, vitamin D has been shown to stimulate steroidogenesis, in one 
study of the effects of the active metabolite of vitamin D, 1,25  (OH)2D3, on human 
ovarian tissue, found it increased progesterone production by 13%, oestrone by 21% 
and oestradiol by 9% (88). It also plays a role in endometrial receptivity and in the 
placenta with 1,25  (OH)2D3 involved in the regulation of placental lactogen, HCG 
expression and secretion in human syncytiotrophoblasts, calcium transport in the 
placenta, as well as decidualisation of the endometrium  (89-91). 
Several studies have found a positive correlation between vitamin D levels 
and AMH levels. In particular, that vitamin D supplementation prevents the seasonal 
variation that AMH levels have displayed in various studies  (92-94). 
Polycystic ovarian syndrome (PCOS) has been much studied in the context of 
vitamin D. PCOS is characterised by oligomenorrhoea, morphologically polycystic 
ovaries on ultrasound, increased ovarian and adrenal androgen secretion resulting in 
hyperandrogenic symptoms (hirsutism, acne). Many women with PCOS will be 
overweight or obese and demonstrate insulin resistance. Several studies have 
demonstrated that vitamin D deficiency is more common amongst women with 
polycystic ovarian syndrome when compared with healthy controls  (95, 96). 
However, it is difficult to clearly elucidate how significant the contribution vitamin D 
makes to the PCOS phenotype, particularly obesity and insulin resistance  (97). These 
studies raise the suggestion that vitamin D measurements and supplementation may 
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have a role in the standard management of PCOS and associated ovulatory 
dysfunction. 
In males the role of vitamin D is less clear. Calcium plays an important role in 
spermatogenesis, sperm motility and the acrosome reaction of fertilisation. 
Blomberg at al demonstrated an association between serum vitamin D levels and 
increased intracellular Ca+2 concentration and sperm motility as well as inducing the 
acrosome reaction (98). Other authors have not found such an association but 
suggested that low and high serum levels of vitamin D had a negative effect on sperm 
count, sperm motility and morphology  (99). 
Vitamin D and IVF outcome has been investigated by several authors, without 
reaching a clear consensus. Ozkan et al. found that women with higher serum and 
follicular fluid 25 (OH) D levels had higher implantation rates and a significantly 
higher clinical pregnancy rate following IVF. The study also found that each 1ng/mL 
increase in follicular fluid concentration of 25 (OH)D increased by 6% the chance of 
clinical pregnancy (100). Several other studies however have found no clear 
association between serum or follicular levels of 25 (OH)D and IVF outcomes  (101, 
102). 
Interestingly, Budick et al reported on the impact of serum vitamin D levels in 
donor oocyte cycles. This study found that the vitamin D deplete recipients had a 
significantly lower rate of clinical pregnancy and live birth (37% v 78% and 31% v 59% 
respectively) when compared to vitamin D replete recipients. These findings 
suggested vitamin D may play a more important role through the effects it has on the 
endometrium than those on the follicle or oocyte  (103). A similar study in the same 
46 
 
year however showed no difference in pregnancy rates or ongoing pregnancy rates 
between vitamin D replete and deplete oocyte recipients  (104). 
There is certainly a suggestion that vitamin D plays a role in the reproductive 
process in males and females but due to the lack of clarity on the exact mechanism 
by which it exerts its effect there remains no consensus on the benefit of vitamin D 
measurements and supplementation in the IVF population.  
 
1.4.6 Alcohol 
Alcohol consumption is associated with adverse health effects, however, the 
effect of alcohol on fertility is difficult to establish, particularly the level of alcohol 
consumption at which it becomes harmful. Most studies in the literature indicate a 
detrimental effect on fertility. A prospective study by Jensen et al reported-on 
fecundity of 430 Danish women, over six menstrual cycles where alcohol 
consumption was monitored over 1 week each month. The study found that the 
chance of a successful conception decreased with increasing alcohol intake, OR 0.61  
(10 - 50g alcohol per week) to 0.34  (100g alcohol per week)  (105). Similar findings 
were reported by Hakim et al in another prospective study of 124 ovulating women, 
this time combined with cigarette smoking. Non-drinkers of alcohol who did not 
smoke had a rate of conception of 24.5%, compared with 21.6% for non-drinkers who 
smoked, 14.3% for women drinking 1 - 12g alcohol per week, 10.5% (13 - 90g alcohol 
per week) and 10.9% (> 91g alcohol per week).  
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A Danish study by Juhl et al of 29,844 planned pregnancies, where 79% of 
women reported up to 7 drinks per week  (where one drink equalled 12g alcohol) 
and 12% reported no alcohol intake at all in the time leading up to pregnancy, found 
no significant correlation between moderate alcohol consumption and increased 
time to pregnancy. In contrast to other studies, they identified a possible detrimental 
effect of no alcohol consumption on time to pregnancy. 
High levels of alcohol consumption in males is associated with profound 
effects on Leydig cell function by decreasing testosterone synthesis and membrane 
damage resulting in the development of Leydig cell auto-antibodies due to the 
presence of acetaldehyde. However, reports in the medical literature also 
demonstrate conflicting results at moderate alcohol intake levels with some studies 
indicating no effect on sperm parameters  (106-108) and other studies indicating 
harmful effects  (109-111).  
There are several studies in the literature demonstrating a detrimental effect 
of alcohol consumption, by both the male and female partner, on the success rates 
of IVF treatment. One study found that female alcohol consumption was associated 
with lower oocyte numbers at retrieval  (OR 0.87, CI 0.77 - 0.98, p = 0.02), chance of 
pregnancy  (OR 2.86, CI 0.99 - 8.24, p = 0.05) and increased risk of miscarriage  (OR 
2.2, CI 1.09 - 4.49, p = 0.03). For men, one additional alcoholic drink per day in the 
month leading up to oocyte retrieval increased the risk of not achieving a live birth 






Exercise, in moderation, is an essential part of a healthy lifestyle and has no 
negative impact on reproductive health  (113, 114). Managing weight gain through 
moderate exercise is beneficial, not only to reproductive health, but to general 
medical health. 
In terms of achieving a pregnancy, moderate exercise increases insulin 
sensitivity thus reducing carbohydrate-induced hyperinsulinaemia, which may favour 
embryo implantation. Vigorous exercise however, reduces leptin, which may play an 
important role in regulating embryo implantation  (115).  
There is much research showing that exercise at extreme levels, such as that 
undertaken by female athletes, does have an impact on fertility. Vigorous exercise 
can cause a hypothalamic dysfunction leading to effects on gonadotrophin- releasing 
hormone (GnRH) pulsatility. The reduction in GnRH pulsatility results in a limited LH 
and, to a lesser extent, FSH release from the pituitary gland. The result is lower 
ovarian follicle stimulation, lower levels of oestrogen release, anovulation, 
oligomenorrhoea and luteal phase defects thus effecting chances of conception  
(116, 117). 
Several studies have reported on physical activity amongst non-athletes and 
its effect on reproductive function and fecundity. Three studies have evidence of 
lower leptin and progesterone concentrations, particularly in the luteal phase, 
amongst women with high levels of physical activity  (118-120). Similarly, in some 
studies of fecundability, high levels of physical activity have been shown to have 
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negative effects on the chance on conception, while moderate exercise has a 
beneficial effect  (121, 122). 
For those undergoing ART, specifically IVF/ICSI, the findings are somewhat 
similar, though again, are mixed. High levels of regular exercise, 4 hours per week for 
less than 10 years, were shown, in one study, to be associated with lower levels of 
live birth when compared to women not engaged in regular physical activity  (123). 
Gaskins et al however, found regular moderate-to- vigorous levels of exercise  (2.5 
hours per week) to have no negative effect on success from IVF and that certain 
aerobic exercises had a positive effect  (124). Moderate exercise levels before or 
during an IVF cycle show positive effects on pregnancy/live birth, with benefit shown 
particularly in overweight/obese women  (121, 125, 126). 
 
1.4.8 Emotional wellbeing and social support 
Psychological stress is prevalent amongst couples trying to conceive and 
undergoing assisted fertility treatment. Not only does the process of trying to achieve 
a pregnancy spontaneously become stressful with increasing time to conception but 
the weight of expectation associated with fertility treatment is a source of great 
stress.  
It has long been recognised that physical (excessive exercise) and 
psychological stress in a woman of reproductive age manifests physically in disrupted 
menstrual cycles due to the effect on the hypothalamic-pituitary axis  (127). Stress 
hormones such as catecholamines (adrenalin, noradrenaline and dopamine) and the 
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hypothalamic-pituitary-adrenal axis interact with hormones which are responsible 
for normal ovulatory cycles: i.e., gonadotropin releasing hormone (GnRH), prolactin, 
LH and FSH. Hypothalamic-pituitary axis activation leads to increased cortisol 
production and a delay or inhibition of pre-ovulatory GnRH and LH surge. This results 
in delayed ovulation, a shortened luteal phase and irregular menses, limiting the 
opportunity of the female to conceive  (128, 129). 
There is no doubt that couples undergoing IVF treatment feel stress and that 
it is one reason for dropout rates from treatment  (130, 131). The difficulty arises 
when separating cause and effect, particularly when determining the effect of stress 
on success of IVF treatment.  Reflecting this is a growing number of studies with 
conflicting results regarding the impact of stress on IVF success  (132-135). A meta-
analysis by Matthiesen et al reviewed 31 prospective studies of 4902 women, for 
stress or distress, including anxiety and depression. They found a small but significant 
effect of stress and anxiety on clinical pregnancy rates but this significance did not 
occur for positive pregnancy test and live birth rate. The latter might be explained by 
under-powered studies and the heterogeneity between studies as the authors admit 
that the discrepancy is not biologically plausible  (136). Boivin et al followed up with 
a meta-analysis including 14 studies of 3583 women prior to their first IVF cycle and 
found no significant impact of emotional distress on the outcome of an IVF cycle. 
There was a significant pooled standardised mean difference indicating more distress 
amongst the not pregnant group when positive pregnancy test was used as the 
definition of pregnancy, this difference was not seen when positive ultrasound scan 
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or live birth were used  (137). The findings of these meta-analyses reflect the 
difficulty in elucidating the true effect of stress on the outcome of IVF. 
There is more robust data however on the effect of stress on early pregnancy 
success, which ultimately impacts on the success, if it is to be measured in terms of 
live birth, of an IVF treatment cycle. There is evidence to suggest the high perceived 
stress by pregnant women in early pregnancy is associated with increased rates of 
miscarriage. Immunological imbalances have been linked to miscarriage in those who 
reported high perceived stress and women who reported feeling stressed, anxious, 
depressed, out of control or overwhelmed in their first trimester had higher odds of 
miscarriage  (138, 139). 
 
1.4.9 Physical characteristics of the uterus 
The exact contribution of the physical characteristics of the uterus to the 
outcome of ART is the relative unknown of the treatment cycle.  
Uterine fibroids are one of the more accessible characteristics to study. 
Uterine fibroids are common, benign tumours of the uterus increasing in prevalence 
with increasing age and more common in certain ethnicities. Fibroids are classified 
according to their position in the uterus - subserosal fibroids, intramural fibroids and 
submucosal fibroids. Fibroids are estimated to be present in 5 - 10% of subfertile 
women. In 1 - 2% of subfertile couples the cause may be due to fibroids alone.  In this 
case it is usually due to distortion of the endometrial cavity by submucosal fibroids, 
typically with a significant endometrial component.  
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A systematic review by Pritts et al on the impact of fibroids on fertility and 
the benefit of myomectomy indicated that subfertile women with submucosal 
fibroids had decreased implantation rates and clinical pregnancy rates compared 
with subfertile women without fibroids. It was concluded that excision of submucosal 
fibroids is likely to incur benefit in improving fertility outcomes. The data regarding 
intramural fibroids was less conclusive due to poor study quality. There is a 
suggestion of decreased fertility and increased rates of miscarriage amongst this 
group with no significant benefit from myomectomy. Subfertile women with 
subserosal fibroids had similar outcomes to those without fibroids  (140). 
Congenital abnormalities of the uterus can also affect fertility by reducing 
implantation and increasing pregnancy loss. Müllerian duct anomalies arise during 
embryogenesis, from a failure of the Müllerian ducts to either properly fuse or failure 
in their correct development. This results in an array of structural aberrations of the 
uterus.  The most common abnormality is the septate uterus. This may be a mild 
septum bulging into the uterine cavity or the septum may extend varying distances 
into the uterine cavity with the most severe being a complete septum. Diagnosis is 
typically made by a combination of transvaginal ultrasound and laparoscopy and 
hysteroscopy. A septate uterus is associated with the highest incidence of subfertility 
and may be associated with first- and second-trimester pregnancy loss and preterm 
labour  (141). A review by Homer at al found that in women with septate uteri, 79% 
of pregnancies resulted in miscarriage with the underlying mechanism being a poor 
blood supply to the septum thus impairing implantation  (142). 
53 
 
In women without uterine abnormalities, little is understood about the effect 
of uterine factors on fertility. Uterine dimensions have been studied by few groups 
in order to determine the effect of uterine length on pregnancy outcome following 
IVF. Many of the studies were performed in order to determine the optimum 
distance into the uterine cavity at which to place embryos during embryo transfer. 
The length of the uterus was determined by uterine sounding using a uterine sound 
or the embryo transfer catheter. The length was therefore from the external os to 
the uterine fundus. Egbase et al reported highest implantation and clinical pregnancy 
rates in women with a uterine length of 7 - 9cm, although the findings were not 
significant. The study also reported a non-significant finding of a higher rate of 
ectopic pregnancy among the group with smaller  (< 6cm) uteri  (143). 
Hawkins et al studied the uterine length of 5120 women by uterine sound in 
the cycle preceding IVF treatment and the subsequent pregnancy outcomes 
according to length. Of note, the study did not record parity of the study participants. 
The median length of the uterus was 7cm. Women with small uteri  (< 6cm), when 
compared with those in the referent group  (7 - 7.99cm), were half as likely to achieve 
a live birth  (RR: 0.53, 95% CI: 0.35 - 0.81) and more likely to have spontaneous 
miscarriage  (RR 2.16, 95% CI: 1.23 - 3.78). Those with uteri 6 - 6.99cm, when 
compared to the referent group were also less likely to achieve a live birth (RR: 0.91, 
95% CI: 0.85 - 0.98). The study also found that women with larger uteri > 9cm had a 
non-significant reduction in chance of live birth with compared to the referent group. 
There was a positive association with higher BMI > 30kg/m2, increasing quartiles of 
weight and increasing quartiles of height and larger uterine lengths. The authors 
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suggesting that larger uteri act as an intermediate in the relationship between 
obesity and decreased success from fertility treatment  (144).  
Ultrasound is routinely used in IVF/ICSI cycles to assess the endometrium and 
to monitor follicular growth in order to time oocyte retrieval. There has been much 
focus on three-dimensional evaluation of the endometrium and endometrial 
vascularity in order to predict pregnancy from IVF treatment  (145-147). There are 
no published data on pre-conceptual ultrasound evaluation of the uterus as an aid to 
predict preterm delivery, particularly in twin pregnancy. One group reported 
ultrasound evaluation of the uterus (hysterosonometry) prior to conception to 
predict preterm birth by measuring the size of the uterus  (external so to fundus). 
The study was small  (n = 79) however, they reported a statistically significant 
correlation between smaller uteri  (< 63mm in length from external cervical os to 
fundus) and preterm delivery  (148). The advent of three-dimensional ultrasound has 
allowed more accurate assessment of uterine volume when compared to two- 
dimensional ultrasound  (149).  
  
1.5 Risks of ART 
 
ART due to the invasive nature of the treatment carries small risks of sepsis 
secondary to oocyte retrieval and trauma to intra-abdominal organs at the time of 






1.5.1 Ovarian hyperstimulation syndrome  
The most significant risk of ART is the risk of ovarian hyperstimulation 
syndrome (OHSS) associated with superovulation with gonadotrophins. Women 
most at risk are those with polycystic ovaries and women under 30 years of age i.e. 
those with a good ovarian reserve (high AFC or high AMH). The true incidence is 
difficult to establish as there is no requirement for mandatory reporting of mild – 
moderate OHSS but is estimated to occur in 1 - 10% of IVF patients, with severe cases 
estimated at 0.25 - 2%. OHSS can lead to significant morbidity and is potentially fatal, 
particularly if poorly managed  (152). 
The pathophysiology of OHSS is not fully understood. It involves a sudden 
increase of vascular permeability in response to hCG or LH following super-ovulation 
with gonadotrophins. The vascular permeability results in third-spacing of fluid and 
intravascular depletion and haemoconcentration. Haemoconcentration results in an 
increased risk of thromboembolism. The third spacing of fluids most frequently 
clinically manifests as ascites and less commonly pleural or pericardial effusions. 
OHSS is graded according to severity- mild, moderate, severe and critical- 
according to the severity of symptoms, ovarian size, degree of ascites and 
haematological changes. 
There are two subtypes of OHSS- early and late- according to the time of 
occurrence in relation to the number of days from oocyte retrieval. Late OHSS always 
occurs in the presence of hCG from a pregnancy and therefore the condition may be 
more protracted. Early OHSS in the absence of a pregnancy occurring  (no embryo 
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transferred in anticipation of OHSS or unsuccessful embryo transfer) is more likely to 
be self-limiting  (153, 154). 
 
1.5.2 Multiple pregnancy 
Multiple pregnancy comprises twin pregnancy and higher order multiple 
(HOM) pregnancy including triplets, quadruplets etc. All multiple pregnancies are 
described according to their zygosity. A dizygotic twin pair results from two separate 
fertilised ova whereas monozygotic twins result from a single fertilised ovum. The 
twin pair is further described according to the chorionicity. All dizygotic twins have 
two placental masses, which are usually separate, and separate amniotic sacs and 
are described as dichorionic diamniotic twins. The chorionicity of monozygotic twins 
depends on the timing of embryo division- dichorionic diamniotic (3 days), 
monochorionic diamniotic  (4 to 8 days), monochorionic monoamniotic  (8 to 12 days) 
and conjoined twins  (division after 13 days)  (155). Monozygotic twin rates have 
remained relatively stable over time at approximately 4 per 1,000 maternities  (156). 
Spontaneously conceived dizygotic twins are associated with increasing maternal 
age, higher parity, and family history of twinning, all thought to be related to higher 
circulating levels of FSH in the mother  (157, 158). The worldwide rate of dizygotic 
twinning has increased substantially over the past number of decades due to an 
increase in iatrogenic twinning associated with ART treatments, particularly IVF. 
Monozygotic twinning is also increased with IVF  (two to five fold)  (159). The 
increased frequency of monozygotic twins may be associated with breaks in the zona 
pellucida associated with handling the embryo in the laboratory for techniques such 
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as ICSI or associated with other laboratory conditions such as culture medium  (158). 
Dizygotic twinning from ART is associated with the transfer of two embryos into the 
endometrial cavity. 
It is widely accepted that multiple pregnancy, irrespective of mode of 
conception, is associated with a higher rate of both maternal and perinatal morbidity 
and the risk of same increases with increasing number of fetuses in the pregnancy  
(160, 161). Perinatal morbidity and mortality is increased 4- to 10- fold in twins 
compared to singletons  (162). The increased perinatal morbidity and mortality are 
largely secondary to the higher rate of pre-term delivery (< 37 weeks gestation). The 
preterm prediction study found that, of 142 twin pregnancies prospectively followed 
to delivery, 54% delivered before 37 weeks, 32% before 35 weeks and 8.8% before 
32 weeks  (163).   
Antenatally, multiple pregnancies have a higher rate of intrauterine growth 
restriction, small for gestational age and congenital malformation than singletons. 
Maternal obstetric complications occur three to seven times more often in multiple 
pregnancy compared with singleton pregnancy and in higher order multiple  (HOM) 
pregnancies compared to twin pregnancy (164). Maternal morbidity includes, 
pregnancy-induced hypertension (PIH), pre-eclampsia (PET), gestational diabetes, 
antepartum- and postpartum- haemorrhage (APH/PPH). Chorionicity is an important 
indicator of perinatal morbidity and mortality. Monochorionic twins are associated 
with higher rates of perinatal morbidity and mortality, particularly for the fetus when 
compared to dichorionic twins (165). Many of the monochorionic-specific 
complications are due to their interdependency on the shared placenta. Discordance 
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in blood supply between the twins can result in discordance in size and amniotic fluid 
volume, as in twin to twin transfusion syndrome (TTTS). Death of one twin can result 
in a 20% risk of death of the surviving twin. It can also result in a 20% risk of ischaemic 
lesions in the brain of the surviving twin  (166). 
Many studies have focused on the impact of mode of conception on risk of 
adverse obstetric or perinatal events with conflicting results. Several studies have 
reported an increased risk of low birth weight, preterm birth  (167-171) whereas 
other studies reported no increased maternal nor perinatal risk conferred by mode 
of conception  (172-175). Indeed, further highlighting the lack of consensus, in one 
systematic review by Helmerhorst et al.  (176) perinatal mortality in twins conceived 
using ART was 40% lower compared with spontaneously conceived twins. Several 
studies have found that ART conceived twin pregnancies had comparable rates of 
maternal antenatal complications when compared to spontaneously conceived twin 
pregnancies, specifically gestational diabetes mellitus, gestational hypertensive 
disorders  (pregnancy-induced hypertension and pre-eclampsia) and obstetric 
cholestasis  (167-169, 175, 177). 
Multiple pregnancies have a significantly higher rate of preterm delivery and 
the degree of prematurity dictates the likelihood of severe neonatal morbidity both 
short-term and long- term. The majority of triplets and all other higher-order 
multiples are delivered prematurely irrespective of mode of conception.  
Multiple pregnancies also carry a significantly higher rate of delivery by 
caesarean section, with all triplets and higher order multiples requiring delivery by 
caesarean section. Several studies have reported a significantly higher rate of 
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caesarean delivery amongst ART twins compared to spontaneously conceived twins  
(178-181). However, some studies have found no significant difference in the rate of 
caesarean delivery according to mode of conception  (168, 170, 175, 182). Several of 
these studies report a very high caesarean section rate (in the order of 90%) whereas 
Lambalk et al. report a much lower rate of caesarean delivery (30% and 37%), 
indicating that institutional differences in management are likely to have a role in the 
variation of results. 
In twin pregnancies, data from several studies and meta-analyses indicate a 
higher rate of moderate preterm delivery amongst ART conceived twins  (5, 183). A 
meta-analysis by McDonald et al., where three studies reporting on moderate 
preterm delivery in ART twins found a combined OR of 1.48  (95% CI 1.05 - 2.10) when 
compared with spontaneously conceived twins  (183). 
European Society for Human Reproduction and Embryology (ESHRE) collects 
outcome data for all IVF/ICSI pregnancies from the reporting fertility clinics. The 
graph below demonstrates that twin and triplet pregnancies carry a high rate of 
preterm (< 37 weeks) delivery whereas the singleton preterm delivery rate remains 
low. The overall preterm delivery rate for all infants across Europe ranges from 5.4 - 




Figure 1.5: Evolution of the proportion of premature deliveries (< 37 weeks gestation) in 
singleton, twin and triplet pregnancies arising from IVF/ICSI in Europe 2006 - 2014. 
Figure extracted from ART in Europe 2014: Results generated from European registries by ESHRE. 
Human Reproduction, Sept 2018, Vol.33, No.9 pp. 1586–1601, 2018 
 
The medical literature indicates that multiple pregnancy outcome is 
improving with more standardised care and that mode of conception does not 
significantly impact on the rate of complications. However, there is no doubt that 
multiple pregnancy carries a significant burden of risk and for this reason should 
remain an adverse outcome in ART. 
 
1.6 Multiple pregnancies and ART- current practice 
 
Since the introduction of assisted conception, in particular in vitro fertilisation 
(IVF) and intra-cytoplasmic sperm injection (ICSI), there has been a large increase in 
the number of multiple pregnancies internationally. Multiple pregnancy, specifically 
higher-order multiple pregnancy  (HOM), arising from ART is now deemed an adverse 
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outcome of the treatment due to impact on both maternal and fetal morbidity and 
mortality  (22, 185). IVF treatment involves decision-making regarding the number of 
embryos to transfer into the uterus. Historically, in a bid to increase pregnancy rates 
from treatment for couples and, as a consequence, the success rates of a clinic, it was 
thought best to transfer two and often three embryos into the uterus. This embryo 
transfer policy resulted in a surge in twins and HOM pregnancies (triplets and 
greater) in obstetric units. In the U.S. from 1980, the beginning of the ART era, the 
total number of HOM pregnancies increased over five-fold within 18 years, with 
similar trends seen elsewhere in the world  (186, 187). Another significant change 
was the number of multiple pregnancies occurring in older women, who have a 
higher background rate of obstetric and perinatal complications, with twin birth rates 
in the U.S. rising 27% for women < 20 years, 80% for women in their 30s and 190% 
for women 40 years or older  (188). 
The affordability of treatment can also influence patient choices and clinical 
practices, specifically there is evidence from the US, where robust health insurance 
will cover the cost of treatment and conversely where, without health insurance, the 
cost to the patient is very high, that health insurance coverage will impact on the 
numbers of embryos transferred and subsequent multiple pregnancy rates  (189). 
Interestingly, there is evidence to suggest that cost of a state-funded reimbursement 
plan for couples, even in countries where the reimbursement is substantial, are 
relatively modest. In a review by Chambers et al of the cost of treatment in developed 
countries, ART treatment accounted for 0.25% or less of total healthcare expenditure 
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in all countries surveyed, including countries who offered state funding  (e.g. 
Scandinavia, Australia) and those with no public finding  (United States)  (190). 
 In these countries providing state funding there is more regulation and 
oversight on treatment outcomes, including stricter regulation on the numbers of 
embryos transferred, in order to maintain a low rate of multiple pregnancy, as the 
evidence shows that the cost of multiple pregnancy substantially exceeds the cost of 
providing ART reimbursement  (191, 192). 
A number of studies have estimated the healthcare costs of care provided for 
ART pregnancies and deliveries and have demonstrated that the economic burden 
for twins and HOM pregnancies is substantially greater, in the region of 3 - 4 fold, 
than that of a singleton pregnancy  (193). 
The increasing rates of multiple pregnancy as a result of ART led to a call by 
the relevant governing bodies for a decrease in multiple embryo transfer in order to 
reduce the number of twin and HOM pregnancies. Since 2009, the Human 
Fertilisation and Embryology Authority  (HFEA) in the UK has been working to reduce 
the multiple birth rate as a result of ART, from 24% in 2008 to 15% in 2015, with an 
ultimate aim of less than 10%, which was achieved in 2017  (194, 195). Elective single 
embryo transfer  (eSET) is the recommended policy for women less than 37 years of 
age or those with several good quality embryos  (18). In the UK HFEA have reported 
that eSET rates have continued to rise  (from less than 5% in 2008 to 29% in 2015) 
without a decline in pregnancy rates  (194). Across Europe there has also been a 





Figure 1.6: Number of embryos transferred in IVF and ICSI during fresh cycles in Europe, 
1997–2014. 
Figure extracted from ART in Europe 2014: Results generated from European registries by ESHRE. 




This is also due to the improvements in cryopreservation techniques, namely 
vitrification. This means that one IVF cycle may result in a fresh transfer of a single 
embryo, with less obstetric risk and thus, a higher likelihood of a term live birth. It 
may also yield surplus good quality embryos that can be confidently cryopreserved 
using vitrification and have a high likelihood of resulting in future live births, 
therefore not diminishing the cumulative livebirth rate. This scenario is most likely to 
arise in younger women with good ovarian reserve and good egg quality and thus is 
the reason for the recommendation for eSET in women less than 37 years old. 
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Vitrification was first introduced in Cork Fertility Centre in March 2012. The eSET rate 
in Cork Fertility Centre was 12.2% in 2013, increasing to 12.9% in 2014. 
In Ireland, over the last decade  (2002 - 2011), there was an increase of 52.7% 
in the number of liveborn twins delivered and a similar trend has been noted in other 
countries  (162, 196, 197). Currently there is no governing body dedicated to 
overseeing ART in Ireland, therefore many clinics have adopted the 
recommendations from the UK’s HFEA. Without a governing body to supervise a 
strict eSET policy, there continues to be high rates of multiple pregnancies in Ireland 
(see Table 1.6 and 1.7). The Healthcare Pricing Office and Health Service Executive in 
Ireland Perinatal Statistics Report 2016 demonstrates an increase in the twinning rate 
of 22.1 per cent over the decade 2007 - 2016 and a 1.6 per cent increase between 
2015 and 2016. The lack of a governing body also results in a lack of mandatory 
reporting by Irish fertility clinics to help ascertain the contribution ART is making to 
the multiple pregnancy numbers. A varying number of the seven fertility clinics based 
in Ireland voluntarily report to ESHRE each year and the results of their most recent 
reports are shown in Table 1.7 and Table 1.8. There is a rise in the number of single 
embryo transfers and a consequent fall in the number of multiple embryo transfers 
over this time period indicating a change in practice in Irish fertility clinics in line with 




Table 1.6: Single and multiple births (both livebirth and stillbirth) in Ireland 2007-2016 







Singleton 69692 72916 73603 73046 71651 69452 66650 65070 63384 61655 -11.5 -2.7 
Twin 2185 2575 2373 2480 2638 2435 2526 2461 2390 2363 8.1 -1.1 
Triplet 86 96 43 74 88 99 91 79 95 79 -8.1 -16.8 
Twinning Rate 15.4 17.4 15.9 16.7 18.1 17.2 18.6 18.5     
Twinning rate- per 1,000 maternities. 






Table 1.7: Irish fertility clinic data as reported to ESHRE 2008 - 2014 demonstrating numbers of embryos transferred and subsequent delivery 
data from IVF/ICSI embryo transfers. 
Year No. Clinics 
 (n = 7) 




2014 3 851 349 (41) 492 (57.8) 10 (1.2) 0 
 
331 49 (14.8) 1 (0.3) 
2013 3 894 339 (37.9) 517 (57.8) 38 (4.3) 0 
 
308 52 (16.9) 0 
2012 4 1624 624 (38.4) 907 (55.8) 93 (5.7) 0 448 62 (13.8) 2 (0.4) 
2011 5 1783 581 (32.6) 1047 (58.7) 154 (8.6) 1 (0.1) 472 75 (16.2) 0 
2010 6 2425 679 (28) 1535 (63.3) 206 (8.5) 5 (0.2) 685 130 (19) 5 (0.7) 
2009 6 2487 640 (25.7) 1639 (65.9) 208 (8.3) 0 627 137 (21.9) 6 (1.0) 
2008 5 2207 422 (19.1) 1602 (72.6) 181 (8.2) 2 (0.1) 618 127 (20.6) 8 (1.3) 
Data presented as n (%) where available 






Table 1.8: Irish fertility clinic data as reported to ESHRE 2008 - 2014 demonstrating 
numbers of frozen embryos thawed and subsequent delivery data from frozen 
embryo transfers. 






Deliveries Twins  
n (%) 
Triplets 
2014 3 385 80 7 (8.8) 0.0% 
2013 3 371 77 5 (6.5)  
2012 4 716 101 9 (8.9) 0.0% 
2011 5 762 124 9 (7.3) 0.0% 
2010 6 882 123 13 (10.6) 0.8% 
2009 6 744 114 9 (8.0) 0.0% 
2008 5 672 91 11 (12.1) 1.1% 
 
1.7 Singleton pregnancy following ART 
 
There is evidence that ART singletons have increased perinatal risks when 
compared to spontaneously conceived singletons. Studies show increased rates of 
pre-term delivery, low birth-weight and cerebral palsy even following adjustment for 
factors such as maternal age and parity  (176, 199). The reasons for the increased 
adverse outcomes are poorly understood. Many studies have suggested that the 
underlying subfertility may itself be a risk factor with studies showing higher rates of 
adverse outcomes associated with increasing duration of involuntary childlessness. 
The limitations of many of these studies are that subfertile women are compared to 
healthy fertile women  (200). 
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Two studies adopted a sib-ship design in order to homogenise the patient 
population, by comparing outcomes between ART-conceived and non-ART conceived 
siblings- both found higher perinatal adverse outcomes in the ART-conceived sibling, 
in particular higher rates of pre-term delivery. The study by Romunsdstad et al found 
no difference after adjusted analyses, leading the authors to conclude that the 
subfertility, rather than the ART process, was implicated  (201). The study by Aaris- 
Henningsen et al found a reduced but persistent increased perinatal risk following 
adjustment, concluding that the treatment process may also play a role in adverse 
outcome  (202). 
There have been suggestions that the embryo culture media may also play a 
role. One study by Kallen et al 2010 demonstrated a decline in adverse perinatal 
outcomes over time which may suggest that improvements in IVF techniques, 
including milder controlled ovarian hyperstimulation (COH), better culture media 
and increased eSET may have an impact.  
Studies on the outcomes of pregnancies conceived from frozen embryo 
transfer  (FET) show a lower rate of small for gestational age infants  (SGA) with some 
studies showing an increased rate of large for gestational age  (LGA) infants when 
compared to fresh embryo transfer  (203-205). Again, the sib- ship study by Aaris- 
Henningsen 2011 showed that, following adjustment for age and birth order, siblings 
born from FET had a higher mean birthweight compared to their spontaneously 
conceived sibling (202). This once again suggests that the laboratory process, perhaps 




1.8 Vanishing twin syndrome following ART 
 
Vanishing twin syndrome (VTS) has been identified as a potential risk factor 
for obstetric complications, in particular pre-term delivery and low birthweight. 
Vanishing twin syndrome (VTS) is estimated to affect between 12 - 30% of 
pregnancies following ART (206). VTS is the phenomenon whereby more than one 
gestational sac is present on early ultrasound but due to loss of the second sac/fetus, 
the pregnancy continues as a singleton. Several studies have demonstrated an 
increased rate of adverse perinatal outcome for VTS singletons. A recent large study 
of 113,784 livebirths from fresh and frozen ART cycles in the UK, by Kamath et al 2018 
demonstrated an increased risk of pre-term birth and low birthweight among VTS 
singletons when compared to singletons with only one gestational sac at early 
ultrasound (irrespective of whether single or double embryo transfer had occurred). 
These findings are consistent with a number of other prior studies (207, 208). Pinborg 
et al studied 8542 women and identified a 1.7-fold increased risk of low birth weight 
and a 2.3 - fold increased risk of very low birth weight in liveborn singletons 
originating from a VTS pregnancy when compared with liveborn singletons from a 
singleton pregnancy. The study also found that obstetric risks increased the later in 
pregnancy that spontaneous reduction occurred  (209). 
Sazonova et al performed a large population-based registry study of 13,544 
children born from IVF (fresh transfer, frozen transfer, eSET, double embryo transfer, 
donor oocytes, singletons and multiples). Their obstetric outcomes were compared 
with spontaneously conceived children of the general population. This study 
demonstrated that IVF children, irrespective of numbers of embryos transferred or 
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multiplicity, had poorer obstetric outcomes, particularly in terms of pre-term 
delivery, low birth weight and very low birthweight  (210). 
 
 1.9 Summary 
 
Assisted reproductive technologies are now well-established treatment 
options for couples with subfertility with increasing numbers of couples undertaking 
IVF/ICSI in order to achieve a pregnancy.  
The success of IVF is also improving, particularly with advancements in 
embryology and cryopreservation (211). This has resulted in IVF/ICSI treatment 
becoming more applicable to a broader population, allowing women/couples who 
previously may not have had the hope of conceiving such as older or menopausal 
women or couples with significant hereditary genetic conditions to consider 
pregnancy. 
However, the treatment process is fraught with anxiety and stress for couples 
who are hoping for a much-wanted baby. Furthermore, it carries increased risks both 
directly and indirectly related to the process. OHSS is of particular concern and 
women at risk of this condition require careful management and counselling. 
Multiple pregnancy carries increased obstetric risk for both mother and fetuses, 
particularly associated with pre-term delivery, with an associated financial burden on 
the state in providing the necessary care. Iatrogenic twinning due to the transfer of 
two embryos is preventable. Therefore, appropriate patient selection for elective 
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single embryo transfer (eSET) should be encouraged in order to reduce the frequency 
of multiple pregnancy.  
There is increasing focus on the physical characteristics and pre-conceptual 
health of the couples undergoing fertility treatment. Obesity has been shown to be 
associated with poorer IVF outcomes and is a risk for obstetric complications, 
gestational diabetes in particular and its associated complications. Smoking, alcohol 
and diet are also known to have negative effects on IVF treatment outcomes. 
Less is known about the contribution of the physical characteristics of a 
normal uterus, to both treatment and pregnancy outcome. There is an indication the 
women with smaller uteri have a lower chance of ongoing pregnancy but the studies 
on this are few. There is no study regarding the combination of multiple pregnancy 
and smaller uteri on obstetric outcome, in particular the risk of preterm delivery, 





The overall objective of the thesis was to identify any pre-cycle characteristics 
that may indicate a negative impact on IVF success rates or increased obstetric risk. 
The original hypothesis was that pre-cycle characteristics, particularly uterine volume 
and dimensions, could be identified prior to an IVF cycle, as being associated with a 
higher risk of pre-term labour and adverse pregnancy outcome, therefore allowing a 
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more individualized embryo transfer policy i.e. where a woman was at lower risk for 
preterm delivery she could be selected for double embryo transfer. The approaches 
planned to fulfil the objectives are detailed in the studies outlined in sections below. 
 
The Retrospective Study - pregnancy outcomes from ART at Cork Fertility Centre 
(CFC) 2002 - 2013 
This retrospective review, presented in Chapter 2, was undertaken to 
ascertain if pregnancies (both multiple and singleton) resulting from IVF/ICSI at Cork 
Fertility Centre, between 2002 - 2013, were associated with adverse perinatal 
outcome. A more detailed study on dichorionic diamniotic (DCDA) twins (resulting 
from the transfer of two embryos, therefore iatrogenic), was also undertaken, 
comparing them to spontaneously conceived twins, with the aim of assessing 
whether mode of conception conferred excess perinatal risk. 
 
The Prospective Cohort Study of nulliparous women undergoing IVF/ICSI at CFC 
2012 - 2015 
This aim of this prospective review, presented in Chapter 3, was to determine 
if any physical, biochemical, demographic, lifestyle or psychological factors that are 
identifiable prior to treatment may be associated with adverse treatment outcome 
and/or adverse obstetric outcome. Clinical Research Ethics Committee Approval was 
granted for this study  (Appendix i and ii). No funding was sought for this study. 
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The Cross-sectional Study- Assessing the impact of psychological factors on 
treatment outcome 
The aim of this study, presented in Chapter 4, was to determine if 
psychological stressors had an impact on IVF/ICSI treatment cycle outcomes 









































2.1.1 Study design 
This study was a retrospective study firstly looking at all dichorionic, 
diamniotic (DCDA) twins resulting from IVF/ICSI treatment at Cork Fertility Centre 
2002 - 2013 inclusive. DCDA twins were selected as they are iatrogenic twins i.e. as a 
result of the transfer of two embryos, and therefore there is potential to reduce the 
twin pregnancy rate by modifying embryo transfer policy. As discussed in the 
introduction, monochorionic twins do occur after IVF/ICSI due to splitting of a 
blastocyst, however they are not associated with the transfer of two embryos and 
therefore there is no opportunity to modify management (i.e. modify numbers of 
embryos transferred) to impact on monochorionic twin rates.  
A further more detailed review of all DCDA twins conceived from IVF/ICSI at 
Cork Fertility Centre and who delivered at Cork University Maternity Hospital 
between 2009 - 2012 was performed. The time period for this more detailed study 
was selected because in 2009 the dedicated twin clinic was set up in CUMH. The twin 
clinic was consultant led with dedicated midwifery support. All twin pregnancies 
attending the clinic were prospectively documented in a dedicated database with 
details including method of conception (Appendix iii). This enabled the identification 
of cohort of spontaneously conceived DCDA twins. The outcomes of the ART 
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conceived DCDA twin pregnancies were compared to all spontaneously conceived 
DCDA twins who delivered at Cork University Maternity Hospital during the same 
time period in order to ascertain if mode of conception was influential on obstetric 
outcome. 
The second group of patients studied were all singleton pregnancies resulting 
from IVF/ICSI treatment at Cork Fertility Centre 2002 - 2013 inclusive. Unfortunately, 
it was not possible to identify spontaneously conceived singleton pregnancies, who 
might have served as a control group, as data was not routinely or reliably collected 
at Cork University Maternity Hospital on mode of conception at this time. Women 
with twin pregnancies had mode of conception noted prospectively in the database 
maintained by the twin pregnancy clinic  (5). However outside of the twin clinic the 
data was neither reliable nor easy to access without requesting the paper charts from 
the archives. A study we published further proved the difficulty with reliable 
documentation of mode of conception. The study, examined the medical charts of all 
oocyte donation pregnancies from Cork Fertility Centre who subsequently delivered 
in CUMH, during the period 2007 - 2012, and noted that only one third of women 
unambiguously disclosed the mode of conception of their pregnancy  (212). 
 
2.1.2 Population/participants 
The groups studied as part of the retrospective study included 
• all women who became pregnant with a twin pregnancy through IVF/ICSI 
treatment at Cork Fertility Centre and subsequently delivered at Cork 
University Maternity Hospital 
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• all women who became pregnant with a singleton pregnancy through 
IVF/ICSI treatment at Cork Fertility Centre 
 
2.1.3 Data collection 
The patient electronic database, IDEAS V. 5.3 ™, Mellowood Medical, Toronto 
Canada, was interrogated to identify those who conceived a twin or singleton 
pregnancy from IVF/ICSI treatment. The data is completed by fertility nurse 
specialists as part of the auditing of IVF/ICSI cycle outcomes. The women are asked 
to complete a proforma with delivery details, birthweight, mode of delivery, gender 
and any pregnancy complications. In the event that the woman does not send in the 
form, the CFC nurses contact the woman to complete the details. The data will be 
collected on every patient as part of the monitoring of success rates. There is 
frequently incomplete data on pregnancy complications, and there may be omissions 
on mode of delivery and birthweight, so data is not always complete (Appendix iv). 
Prior to 2007 the IDEAS database was not in use therefore patient logbooks were 
used to identify the relevant cohort of women from the period 2002 - 2006 (Appendix 
v). These were completed in the same manner. Maternal demographic data including 
age and parity were recorded. Pregnancy outcomes, including gestation at delivery, 
mode of delivery, birth weight and gender were identified from the patient 






2.1.4 Pregnancy outcomes - DCDA twins 
A detailed study of pregnancy outcomes for the DCDA twins conceived with 
IVF/ICSI at Cork Fertility Centre and who delivered at Cork University Maternity 
Hospital between 2009 - 2012 was performed. The outcomes were compared to all 
spontaneously conceived DCDA twins who delivered at Cork University Maternity 
Hospital during the same time period. 
Maternal and obstetric outcomes were recorded from birth records, maternal 
obstetric charts and laboratory data. Specific maternal outcome measures included 
gestational hypertensive disorders; either pre-eclampsia  (defined as persistent 
blood pressure measurements of ≥ 140/90mmHg after 20 weeks gestation with 
associated proteinuria > 300mg/24 hours) or pregnancy induced hypertension  
(persistent blood pressure readings ≥ 140/90mmHg, without associated proteinuria, 
occurring after 20 weeks gestation), gestational diabetes mellitus  (diagnosed by oral 
glucose tolerance test at approximately 28 weeks gestation), obstetric cholestasis  
(pruritus and deranged liver transaminases with elevated serum bile acids), gestation 
at delivery, onset of labour  (i.e. spontaneous or induced labour) and mode of 
delivery. 
Perinatal outcomes were recorded from birth records, maternal obstetric 
charts and neonatal intensive care (NICU) database. These data were collected from 
BadgerNet Neonatal database (Clevermed, Edinburgh, Scotland) in NICU at CUMH. 
The BadgerNet Neonatal system is a contemporaneous, electronic record of events 
during the neonatal admission including delivery events.  Perinatal outcome 
measures included second trimester spontaneous reduction, intrauterine fetal 
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demise or stillbirth of one twin  (≥ 24 weeks gestation and/or weighing 500g or more), 
intrauterine growth restriction  (IUGR; defined as estimated fetal weight less than 
tenth percentile for gestational age), prematurity  (defined as birth occurring at less 
than 37 weeks gestation), degree of prematurity; extremely preterm  (< 28 weeks 
gestation), very preterm  (28 - 31+6 weeks gestation), moderately preterm  (32 - 33+6 
weeks gestation) and late preterm  (34 - 36+6 weeks gestation), birth weight, low 
Apgar score  (defined as < 5 at 1 minute and/or < 7 at 5 minutes), NICU admission 
and mean length of stay  (days) in the NICU and a composite measure of perinatal 
morbidity included any of the following: hypoxic ischaemic encephalopathy  (HIE), 
necrotising enterocolitis  (NEC) and/or sepsis.   
 
2.1.5 Pregnancy outcome - vanishing twin syndrome 
A proportion of pregnancies that were confirmed as twin pregnancies on 
ultrasound scan at 6 and/or 8 weeks gestation resulted in loss (miscarriage, 
intrauterine demise (IUD)) of one twin, known as spontaneous reduction or 
Vanishing Twin Syndrome (VTS). VTS outcomes were compared with singleton 
pregnancy (those pregnancies that had a single intrauterine gestational sac, with or 
without a single fetal pole, on first trimester scan) outcomes.  
 
2.1.6 Pregnancy outcome - singletons 
Singleton pregnancies were defined by the presence of a single intrauterine 
gestational sac, with or without a single fetal pole, at first trimester ultrasound scan. 
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The pregnancy outcomes for the singleton pregnancies conceived by IVF/ICSI 
included the following pregnancy- biochemical pregnancy, first trimester 
miscarriage, second trimester miscarriage, intrauterine fetal demise, neonatal death, 





During the defined study period for the retrospective cohort 2,456 
pregnancies resulted from IVF/ICSI treatment. 13.4% (n = 331) of positive pregnancy 
tests resulted in a biochemical pregnancy. 73% (n = 1791) were singleton pregnancies 
and 13.6% (n = 334) were twin pregnancies, as defined on ultrasound scan at 6 or 8 
weeks gestation. 
 
2.2.1 Maternal characteristics 
The women were studied according to age, parity, previous ART and 
pregnancy outcome. There was no difference between the women who had a 
biochemical pregnancy and those that continued pregnancy. As regards those 
women who had previous assisted reproductive treatment other than IVF/ICSI there 
was no difference in the numbers of women who conceived singletons or twins 
(67.4% versus 61.8%). Similarly, there was no difference in the rates of those who 
had a previous pregnancy (miscarriage) from IVF/ICSI for mothers who conceived 
singletons or twins (26.8% versus 20.2%). On average, women who conceived twins 
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were older than those who conceived singletons (36.2 years, SD ± 3.4 years versus 
35.3 years, SD ± 3.8 years). 
 
2.2.2 Singleton pregnancy outcomes 
As displayed in Table 2.1, 80.2% (n = 1435/1790) of singleton pregnancies 
resulted in a livebirth. There were 4 neonatal deaths (0.3%; n = 4/1791). The rate of 
early miscarriage was 18.9% (n = 340/1790) (Table 2.1). 
Over half of singletons were delivered by vaginal delivery (54.3%; n = 
710/1306). One third (29.9%; n = 390/1306) were delivered by elective caesarean 
section and the remainder required emergency caesarean section (15.8%; n = 
206/1306). The vast majority of singleton pregnancies were delivered at term (93.4%; 
n = 1297/1389), 5% (n = 70/1389) were delivered at late pre-term gestation (34 - 
36+6 weeks gestation). Delivery data was incomplete for n = 129 singleton 
pregnancies. 
 
2.2.3 Twin pregnancy outcomes 
There were 291 twin pregnancies, of which 86.8% resulted in a livebirth of 
one or both twins (n = 449 liveborn babies). Almost half of all twin pregnancies 
resulted in a livebirth of both twins (47.2%; n = 158/335). However, two of the 
liveborn twin pairs experienced a neonatal death of one twin (Table 2.1). 
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39.7% (n = 133/335) of twin pregnancies resulted in the livebirth of only one 
twin. Spontaneous reduction (vanishing twin syndrome, VTS) of one twin occurred 
most frequently due to early miscarriage (37.6%; n = 127/335) (Table 2.1). 
Only 13.4% (n = 45/335) of twin pregnancies did not result in a livebirth, most 
frequently due to early miscarriage of both twins (11.1%; n = 37/335). One twin 
pregnancy resulted in intrauterine demise of both twins (Table 2.1). The majority, 
67.2% (n = 300/448) of liveborn twin infants were born at term gestation (≥ 37 weeks 
gestation). A further 20.8% (n = 93/448) liveborn twin infants were born at late pre-
term gestation (34 - 36+6 weeks gestation). The range of gestations at birth was 41+6 
weeks gestation – 25 weeks gestation for liveborn twin infants. 
Gestation at delivery was analysed according to infants where both infants of 
a twin pair were liveborn to those infants that started out as confirmed twin 
pregnancies but spontaneously reduced to liveborn singleton (Vanishing Twin 
Syndrome; VTS). VTS twins were significantly more likely to result in a term delivery 
(92.4%; n = 122/132 v 56.5%; n = 179/318, p = 0.000). The gestational age range of 
spontaneously reduced twins was 41+6 – 25 weeks gestation compared with a 
gestational age range of 39+4 - 25+2 weeks gestation for infants of a twin pair where 
both twins were liveborn.  
Twins were most commonly delivered by elective caesarean section (37.3%; 
n = 162/434 babies) and 30.9% (n = 134/434) being delivered by vaginal delivery (data 
was incomplete on the mode of delivery of 15 babies). However, when the figures 
are divided into both babies liveborn versus livebirth of only one infant (VTS twin 
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pregnancy) the latter are significantly more likely to be delivered vaginally (42.5%; n 
= 51/120 v 26.4%; n = 83/314, p = 0.003).  
In terms of birthweight, the median birthweight for twins was 2495g ± 645.7g 
with twin one having a significantly higher birthweight than twin two (2889g SD ± 
688g versus 2467g SD ± 575g). Twin two was more likely to be admitted to NNU than 
Twin 1 (38.3% versus 29.2%; p = 0.54). 
 
2.2.4 Singleton pregnancy outcomes versus twin pregnancy outcomes 
 
Pregnancy outcomes of singleton pregnancies versus twin pregnancy were 
analysed and presented in Table 2.2. Singleton pregnancies were more likely to result 
in a livebirth while twin pregnancies were more likely to result in miscarriage (one or 
both twins - 34.4% versus 19.4% miscarriage; p = 0.000). 
Twins were four times more likely to be delivered before 36 weeks gestation 
(27.1% versus 6.5%; p = 0.000) Twins are more likely to be admitted to the NNU than 
singletons (32.6% versus 11.7%; p = 0.000). 
Singleton infants had a significantly higher birthweight than twin infants 






2.2.5 Singleton pregnancy outcomes versus vanishing twin syndrome (VTS) singleton 
outcomes 
A proportion of pregnancies that were confirmed as twin pregnancies on 
ultrasound scan at 6- or 8-weeks gestation resulted in loss (miscarriage, IUD) of one 
twin, known as spontaneous reduction or Vanishing Twin Syndrome (VTS). VTS 
singleton outcomes were compared with singleton outcomes (Table 2.2). 
There was no significant difference in gestation at delivery between the two 
groups (p = .670). VTS singletons were significantly more likely to be delivered by 
emergency caesarean section (24.2%; n = 29/120 v 15.8%; n = 206/1307; p = 0.018). 
There was no significant difference in birthweights between the two groups (3423g 
SD ± 573g v 3387g SD ± 525g; p = .493). There was no difference in the rate of 




Table 2.1: Outcomes of all pregnancies from IVF/ICSI treatment at Cork Fertility 
Centre 2002 - 2013 inclusive 
1 - NND - neonatal death, 2 - IUD - intrauterine fetal demise 
 Number of pregnancies  
(n = 2457) 
Number of 
infants 
Biochemical pregnancies 331 (13.4%)  
Singleton pregnancies 1790 (72.8%)  
Livebirth 1435 (80.2%) 1435 
Livebirth but NND1 4 (0.3%)  
No livebirth 355 (19.8%)  
Early miscarriage 341 (18.9%)  
Late miscarriage 8 (0.4%)  
IUD2 7 (0.39%)  
Twin pregnancies  335 (13.6%) 449 
Livebirth both twins 158 (47.2%) 316 
Livebirth both twins but early NND2 
one twin 
2 (0.6%)  
Livebirth both twins but late NND1 
one twin 
1 (0.3%)  
Livebirth one twin (vanishing twin 
syndrome) 
133 (39.7%) 133 
Livebirth/early miscarriage 126 (37.6%)  
Livebirth/late miscarriage 5 (1.5%)  
Early miscarriage one twin and early 
NND1 of second twin 
2 (0.6%)  
No livebirth 45 (13.4%)  
IUD2 both twins 1 (0.3%)  
Early miscarriage both twins 37 (11.1%)  
Early miscarriage and late 
miscarriage 
1 (0.3%)  
Late miscarriage and ectopic 
pregnancy 
1 (0.3%)  
Late miscarriage both twins 5 (1.5%)  
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Table 2.2: Outcome of singleton and twin pregnancies, including vanishing twin 
syndrome (VTS) singletons. 
 
Data presented as n (%). 1 - VTS - Vanishing Twin Syndrome, 2 - NND - neonatal death, 3 - IUD - 












(n = 133) 
Singleton 
pregnancies 
(n = 1790) 
Livebirth 291 (86.8%) 158 133  1435 
(80.16) 
Livebirth (infants) 449  316 133 1435 
Mode of delivery 
(infants) 
    
Vaginal delivery 134/434 (30.9) 83/314 (26.4) 51/120 
(42.5) *  
 (p = .003 v 
both twins) 
710/1307 
(54.3) *  
 (p = 0.018 v 
VTS) 












Gestation at delivery 
(infants) 
    






34 – 36 + 6 weeks 93/448  
 (20.8) 




























Admission to NNU2 
(infants) 
















NND2 (infants) 4 2  2 4 
IUD3 (infants) 2 2 0 7 
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2.3 Detailed study of DCDA twin outcomes comparing both spontaneous 
conception and IVF/ICSI 
 
The pregnancy outcomes of all DCDA twin pregnancies conceived with 
IVF/ICSI at Cork Fertility Centre and subsequently delivered at Cork University 
Maternity Hospital (CUMH) during the period 2009 - 2012 were analysed. The results 
were compared with the outcomes of all spontaneously conceived DCDA twin 
pregnancies delivered at CUMH during the same period. 
 
2.3.1 Mode of conception 
Five hundred and forty-four women were identified as have an ongoing DCDA 
twin pregnancy at approximately 12 weeks gestation. One hundred and seventy-one 
women (31.7%) had conceived using assisted reproductive technologies (ART). One 
hundred and nine women (63.7%) conceived following IVF treatment, 20.5% (n = 35) 
following ICSI treatment and 15.8% (n = 27) had IVF/ICSI using donor oocyte. 
 
2.3.2 Maternal characteristics 
The mean maternal age of the women was 33.7 ± 5.17 years. Women who 
conceived twins with IVF/ICSI were significantly older 36.8 ± 4.23 years v 32.3 ± 4.93 
years (p <0.001).  Women conceiving with IVF/ICSI were significantly more likely to 
be nulliparous compared to those who spontaneously conceived twins 73.7%; n = 
126 v 36.1%; n = 133 (p < 0.001) (Table 2.3). 
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2.3.3 Maternal outcomes 
There was no significant difference in the frequency of maternal antenatal 
complications between the two groups, specifically gestational diabetes mellitus, 
gestational hypertensive disorders (PET or PIH) and obstetric cholestasis. There was 
a slightly higher rate of gestational hypertensive disorders in the IVF/ICSI group 
compared with the spontaneously conceived group, however it did not reach 
statistical significance and when adjusted for age, parity and type of antenatal care  




Table 2.3: Maternal characteristics of IVF/ICSI versus spontaneously conceived DCDA twin pregnancies  
Maternal characteristics Total population 
n = 539 
Spontaneously conceived 
n = 368 
IVF/ICSI 
n = 171 
Unadj. OR1 
 (95% CI) 
Adj. OR2 (95% CI) P - value 
Mean age (years ± SD) 33.7 ± 5.2 32.3 ± 4.9 36.8 ± 4.2 - - - 
Age range (years) 17 - 51 17 - 46 26 - 51 - - - 
Nulliparity 259 (48.1) 133 (36.1) 126 (73.7) - - < 0.001 
Multiparity 280 (51.9) 235 (63.9) 45 (26.3) - - < 0.001 
Antenatal complications3       
 - GDM4 22 (4.1) 14 (3.8) 8 (4.7) 1.24 (0.66 - 1.81) 0.86 (0.41 - 1.81) 0.709 
- GHD5 100 (18.6) 63 (17.1) 37 (21.6) 1.34 (0.97 - 1.84) 0.81 (0.55 - 1.20) 0.128 
- OC6 21 (3.9) 12 (3.3) 9 (5.3) 1.65 (0.88 - 3.08) 1.39 (0.66 - 2.95) 0.188 
Data presented as n (%) where applicable and unless otherwise stated 
1 Unadj. OR unadjusted odds ratio 
2 Adj. OR - adjusted odd ratio 
3 Antenatal cx - antenatal complications 
4 GDM - gestational diabetes, 
5 GHD - gestational hypertensive disease,  





Induction rates were similar between the groups,  (29.2%; n = 214 
spontaneously conceived group v 24.9%; n = 85 IVF/ICSI group), however 
spontaneously conceived pregnancies were more likely to spontaneously labour than 
IVF/ICSI twins  (31.4%; n = 230 spontaneously conceived v 20.5%; n = 70 IVF/ICSI; p < 
0.001) this is likely due to the higher rate of caesarean delivery  (both elective 
caesarean and emergency caesarean before labour) amongst the IVF/ICSI group.  
(Table 2.4) IVF/ICSI twins were twice as likely to be delivered by caesarean section 
(CS) than those conceived spontaneously (OR 2.35; 95% CI 1.76 - 3.14). This 
association remained after adjustment for confounding variables, specifically 
maternal age, parity and type of antenatal care (AOR 1.45 95% CI (1.03 - 2.03). 
IVF/ICSI twins were more likely to be delivered by emergency CS (OR 2.47, 95% CI 
1.78 - 3.44). 
Almost half (49.7%; n = 536) of all the twin pregnancies in the study group 
were delivered before 37 weeks gestation, most frequently (44.6%; n = 239) 
following spontaneous onset of labour. There was no difference in the rates of 
preterm birth when mode of conception was considered (OR 0.95, 95% CI 0.73 - 1.22, 
p = 0.879) and following adjustment for maternal age, parity and type of antenatal 
care (AOR 0.92, 95% CI 0.68 - 1.28). There was a significantly higher rate of 
spontaneous preterm labour in spontaneously conceived group (49.1% v 34.7%; p < 
0.001). 
The cause of preterm birth was reviewed for each conception group 
(spontaneous onset of labour, induction of labour, elective caesarean section or 
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emergency caesarean section before labour) and is shown in Table 2.4. Almost one-
third (29.9%; n = 50) of ART conceived twins were delivered by pre- labour emergency 
caesarean section compared with 15.7% (n = 58) of spontaneously conceived twins 
(p < 0.001). 
Only 1.5% of babies were delivered at extreme prematurity (< 28 weeks 
gestation), with similar distribution across the spontaneously conceived and IVF/ICSI 
groups (1.6% and 1.2% respectively, p = 0.433) (Table 2.4). IVF/ICSI conceived twins 
were almost twice as likely to be delivered moderately preterm (32 - 33+6 weeks 
gestation) when compared to spontaneously conceived twins (OR 1.98, 95% CI 1.21 
- 3.23). However, when adjusted for maternal age, parity and type of antenatal care, 










Table 2.4: Preterm delivery 
  
Total population  
(n = 536) * 
Spontaneously 
conceived ART conceived  
(n = 167) * 
Odds Ratio 
 (95% CI)  p-value 
 (n = 369) *  
Preterm delivery 536 (49.7) 369 (50.1) 167 (48.8) 0.95 (0.73 - 1.22) 0.879 
Mode of preterm delivery     < 0.001 
Spontaneous onset of labour  239 (44.6) 181 (49.1) 58 (34.7)   
Induction of labour 73 (13.6) 56 (15.2) 17 (10.2)   
Elective CS1 116 (21.6) 74 (20.0) 42 (25.1)   
Emergency CS (pre- labour) 108 (20.1) 58 (15.7) 50 (29.9)   
Gestation at delivery      
≥ 37 538 (50.1) 364 (49.7) 174 (51%) .784 (.586 - 1.04)  
34 - 36+6 385 (35.8) 280 (38.2) 105 (30.8) 1.98 (1.2 - 3.2)  
32 - 33+6 74 (6.9) 38 (5.2) 36 (10.6) 1.18 (.679-2.05)  
28 - 31+6 61 (5.7) 39 (5.3) 22 (6.5) .697 (.222 - 2.1) 
 
< 28 weeks 16 (1.5) 12 (1.6) 4 (1.2)     
 *Values are shown as n (%), where n = number of babies delivered 




2.3.5 Perinatal outcomes 
Perinatal outcomes were similar between the two groups and are shown in 
Table 2.5. There was no difference in the rate of antenatally diagnosed intrauterine 
growth restriction or in the rate of LBW and VLBW babies according to mode of 
conception. A small percentage of twins (3.6%) had a low Apgar score at birth with 
no significant difference according to mode of conception (p = 0.414). Mode of 
conception had no impact on the rate of perinatal death (Table 2.5). 
Of those babies born alive, admission to the NICU occurred in 39.4% of cases, 
with 39% of IVF/ICSI twins and 40.2% of spontaneously conceived twins requiring 
admission (p = 0.384) (Table 2.5). The most frequent indication for admission to NICU 
was prematurity (74.9% of admissions), followed by LBW (51.8%) and RDS (31.4%). 
IVF/ICSI twins were more frequently admitted to Neonatal Intensive Care Unit (NICU) 
for reasons of LBW and for infection risk. A composite measure of neonatal morbidity 
showed no difference between the two groups. IVF/ICSI conceived twins were more 
likely to have neonatal hypoglycaemia and respiratory distress syndrome (RDS) than 
spontaneously conceived twins (p < 0.05) and the association remained when 










(n = 1,078)* 
Spontaneously 
conceived  
(n = 736)* 
ART conceived  
(n = 342)* 
p- 
value 
IUGR 135 (12.5) 98 (13.3) 37 (10.8) 0.146 
Low Apgar score1 38 (3.6) 25 (3.4) 13 (3.9) 0.414 
Mean birth weight:         
Twin 1 (g ±SD) 2492.2 2501.7 ± 540.2 2471.8 ± 557.9 0.554 
Twin 2 (g ±SD) 2461.5 2466.2 ± 552.6 2451.6 ± 559.6 0.777 
LBW2 434 (40.6) 292 (40.1) 142 (41.6) 0.474 
VLBW3 67 (6.3) 42 (5.8) 25 (7.3) 0.474 
Fetal anomaly4 32 (3.8) 24 (3.3) 8 (2.3) 0.267 
Perinatal death5 9 (0.8) 8 (1.1) 1 (0.3) 0.166 
IUFD6 2 (0.2) 2 (0.3) 0 0.466 
NND7 7 (0.7) 6 (0.8) 1 (0.3) 0.293 
NICU admission 423 (39.4) 286 (39) 137 (40.2) 0.384 
Mean length of stay 
NICU (days ±SD) 




69 (16.3) 50 (17.5) 19 (13.9) 0.347 
Hypoglycaemia 25 (5.9) 10 (3.5) 15 (10.9) < .005 
RDS9 91 (21.5) 50 (17.5) 41 (29.9) < .005 
* values are shown as n (%) unless otherwise stated 
1 Low Apgar score defined as Apgar score of < 51 and/or < 75 
2 Low Birth Weight (< 2500g) 
3 Very low birth weight (< 1500g) 
4 Fetal anomaly includes all anomalies except patent ductus arteriosus (PDA) in a premature 
infant 
5 Perinatal Death - death of a fetus at weighing ≥ 500g and /or at ≥ 24 weeks gestation, or 
death of an infant between birth and the end of the neonatal period. 
6 Intrauterine fetal demise 
7 Neonatal death 
8 Composite outcome includes hypoxic ischaemic encephalopathy (HIE), necrotising 
enterocolitis (NEC) and/or sepsis.  





Both singletons and twins conceived from IVF/ICSI had high rates of livebirth 
at term. Twins pregnancies resulted in livebirth of both twins in almost half of all 
pregnancies. Over one-third of twin pregnancies resulted in the livebirth of one twin 
due to VTS and most frequently caused by first trimester miscarriage of one twin. 
VTS singletons were significantly more likely to be delivered at term gestations 
and/or by vaginal delivery than pregnancies that continued as twins. When 
compared to true singleton pregnancies, gestation at delivery was similar but VTS 
singletons had a significantly higher rate of caesarean delivery. 
Twins conceived following IVF/ICSI had a higher rate of caesarean delivery 
and a higher rate of delivery at moderately pre-term gestations. There was no 
difference in perinatal mortality. Associated with this there was a higher rate of RDS 
and neonatal hypoglycaemia. Maternal outcomes were similar with no increased risk 
associated with mode of conception. Overall, twin outcomes were more favourable 
than initially hypothesised, particularly the gestations at delivery, with 1.5% of 









































A prospective study of nulliparous women attending for IVF/ICSI treatment at 
Cork Fertility Centre. 
 
3.1.1    Population 
All nulliparous women attending for IVF/ICSI treatment at Cork Fertility 
Centre were eligible for recruitment. Exclusion criteria were multiparity, previous 
preterm delivery  (spontaneous delivery prior to 37 weeks gestation) or late 
miscarriage  (pregnancy loss between 12 + 1 and 23 + 6 weeks gestation), a history 
of cervical excisional surgery  (Large Loop Excision of the Transformation Zone  
(LLETZ) or knife conisation), pre-existing serious maternal medical disorders that may 
increase risk of pre-term delivery  (e.g. essential hypertension, poorly controlled 
diabetes, epilepsy), the use of confounding treatment  (e.g. elective cervical suture 
placement). BMI was calculated using the formula and measured according to kg/m2. 







3.1.2   Recruitment 
I performed the recruitment and, in my absence, it was performed by CFC 
fertility nurses Margaret O’Donnell, Brid O’Keeffe or Patricia O’Regan RGN. Women 
were selected for recruitment at their appointment for ultrasound scan following the 
downregulation phase of their treatment cycle, if using an agonist protocol, or at 
their baseline ultrasound scan if using an antagonist protocol. The study was 
explained to the woman and if they agreed to participate in the study a short 
proforma was completed, documenting pertinent data. A consent form was signed 
(for sample consent form see appendix vii). Transvaginal ultrasound was performed 
in order to capture 2D and 3D images of the uterus for later measurement. Bloods 
for biochemical markers were routinely performed as part of the work up for the 
IVF/ICSI cycle (see appendix vi) 
 
3.1.3  Ultrasound measurement of uterine dimensions 
All women underwent both a 2-dimensional (2D) and 3-dimensional (3D) 
ultrasound of the uterus as part of the recruitment process using a Voluson™ E8., GE 
Healthcare, US. All images were saved by the operator in a database and according 
to the woman’s study identification number in order that volume measurements 
could be performed.    
In the 2D image the following measurements were performed; length of the 
uterus measured from external os to fundus  (serosal surface), length of uterus 
measured from the external os to the fundus of the endometrial cavity  (identified as 
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the uppermost portion of the endometrium at the endometrial/myometrial junction) 
and cervical length, measured from external os to internal os. Cervical length in a 
non-gravid uterus is difficult to accurately measure given the absence of the amniotic 
fluid-filled gestational sac which serves as a clear marker of the junction between the 
internal cervical os and the endometrial cavity. During the literature review, several 
studies were noted to have a description of cervical length measurement in a non-
gravid uterus, all using an estimation of internal cervical os according to ultrasound 
appearance. Gentry et al 2000 described the cervical length measurement as follows 
‘The length of the cervix was measured to the nearest 0.1 cm in a straight line from 
the internal os along the cervical canal to the external os. Typically, three 
measurements were made and the measurements that most closely demonstrated 
the appropriate landmarks were used’, with another study referencing this method 
also.  (213)  (214) The study by Carcopino et al  (BJOG 2012) on cervical length post-
LLETZ treatment determined the location of internal cervical os ‘the upper limit of 
the cervix was arbitrarily defined as a plane perpendicular to the cervical canal 
positioned at the inferior limit of the endometrial line’  (213, 215).   
A 3D ultrasound image was performed using 3D transvaginal ultrasound 
probe. The images were stored and volume analysis was performed using GE 
Healthcare software 4D view. Uterine volume measurement was performed using 
VOCAL II volume analysis, manually measuring uterine contour in 9◦ rotations. The 




Image 3.1: Sample image of volume analysis report 4D view, GE Healthcare 
 
3.1.4  Follow up of treatment and pregnancy outcomes 
All ongoing pregnancies were analysed for the occurrence of obstetric 
complications. These included gestational diabetes, pre-eclampsia, pregnancy 
induced hypertension, intrauterine growth restriction, pre-term pre-labour rupture 
of membranes, oligohydramnios, placenta praevia, placental abruption and any fetal 
abnormalities including chromosomal and structural. 
 
3.2 Patient characteristics 
 
142 women were recruited for this study according to the inclusion criteria, 
with a mean age of 35.27 ± 3.42. Their partners were older by 3 years on average 
(37.1 years ± 6.077).  The majority of respondents (85%; n = 121/142 women and 
82.4%; n = 117/142 men) were white Irish. Over one third of both male and female 
partners had attended university. Over two thirds of the cohort had a normal body 
mass index (BMI) (18.5 - 24.9 kg/m2) and a further one third were overweight (25 - 
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29.9 kg/m2). Almost all women (90%; n = 122) were non-smokers but over three-
quarters drank alcohol, the majority drinking up to 5 units per week (Table 3.1, 3.2). 
All women were nulliparous, one quarter had a history of first-trimester 
miscarriage, the majority of whom (63.8%; n = 23/36) had conceived spontaneously. 
Almost half of women had undergone other forms of ART- ovulation induction and/or 
intrauterine insemination- prior to IVF treatment (Table 3.2). 
 
Table 3.1: Demographics of recruited women and their partners 
Demographic Woman Partner 
Age (year ± SD) 35.27 ± 3.42 37.1 ± 6.077 
Range (years) 27 - 43 26 - 50 
Ethnicity   
White Irish 121 (85.2) 117 (82.4) 
Irish traveller 1 (0.7) 1 (0.7) 
Any other white 17 (12) 22 (15.5) 
Black/black Irish 1 (0.7) 1 (0.7) 
Asian 0 (0) 0 (0) 
Mixed ethnicity 1 (0.7) 0 (0) 




University 53 (37.3) 49 (35) 
College 41 (28.9) 37 (26.4) 
2nd level 37 (26.1) 41 (29.3) 
Primary level 0 (0) 4 (29) 
Diploma/cert 11 (7.7) 8 (5.7) 





Table 3.2: Characteristics and lifestyle factors of women recruited  
Characteristic Women (n = 142) 
BMI  
Underweight (< 18.5) 3 (2.1) 
Normal (18.5 - 24.9) 90 (63.8) 
Overweight (25 - 29.9) 41 (28.9) 
Obese (30 - 34.9) 6 (4.2) 
Obese Cat 2 (34 - 39.9) 0 (0) 
Obese Cat 3 (≥ 40) 1 (0.7) 
Smoker Yes 16 (11.3) 
< 5 cigarettes/day 6 (4.2) 
5 - 10 cigarettes/day 4 (2.8) 
11 - 20 cigarettes/day 6 (4.2) 
Alcohol Yes 111 (78.2) 
1 - 2 units/week 53 (47.7) 
3 - 5 units/week 39 (35.1) 
6 - 10 19 (17.1) 
Previous miscarriage  36 (25.4) 
Spontaneously conceived 23 (16.9) 
ART conceived 13 (9.2) 




The majority of women (74.8%, n = 101/135) had an appropriate thyroid 
stimulating hormone (TSH) level (≤ 2.5 mIU/l). A small number had high TSH levels > 
4 mIU/L (5.9%; n = 8/135). 
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As regards biochemical assessment of ovarian reserve the majority of women 
had a normal FSH level, indicating normal ovarian function (85.5%; n = 118/142) 
(Figure 3.1). Anti-Müllerian hormone (AMH) levels were performed on 117 women 
(82.3% of the population) as an indicator of ovarian reserve - decreasing levels of 
AMH indicate an increasingly poor ovarian reserve. Almost two-thirds had a low AMH 
level < 15pmol/L (64.1%; n = 75/117) and 12.8% (n = 15/117) had an extremely low 
AMH level (< 5 pmol/L) (Figure 3.2). 
 
 



























Figure 3.2: Serum Anti-Mullerian hormone (AMH) level (pmol/L) 
 
3.4 Ultrasound assessment 
 
Transvaginal ultrasound is used as another tool to assess ovarian reserve. The 
number of antral follicles visible on each ovary are calculated to give an estimate of 
ovarian reserve  (216). Again, the majority (59.8%; n = 85/142) had a combined antral 
follicle count below the normal range. A small number had an extremely low 























Figure 3.3: Combined Antral Follicle Count (AFC) at transvaginal ultrasound 
 
 
3.5 Aetiology of subfertility 
 
The most frequent cause of subfertility among the study cohort was 
diminished ovarian reserve (DOR) (38.7%; n = 55/142), with unexplained subfertility 
and male factor as the next most common aetiologies as shown in Table 3.1. Thirteen 
patients had two factors involved in their subfertility, most frequently was male 

























Combined antral follicle count 
Combined Antral Follicle Count
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Table 3.3: Aetiology of subfertility  
Aetiology Number  Percentage 




Tubal factor 17 12 
Male factor 30 21.1 
Endometriosis 4 2.8 
Ovulatory dysfunction 5 3.5 
Same sex (donor sperm) 1 0.7 
Dual factor 13 9.2 
Dual factor= both male and female partner aetiology 
 
3.6 Uterine characteristics 
 
Transvaginal ultrasound was used to measure uterine dimensions and 3D 
ultrasound technology was incorporated to measure uterine volume. 
The mean length of the uterus measured from the external os to serosal 
surface of the fundus of the uterus was 7.26cm ± 0.88cm. The mean uterine volume 
was 57.33cm3 ± 20.68cm3.   
Uterine volumes and uterine length (external os to fundus) were categorised 
into three groups based on 30th and 70th centile measurements. Small uterus (< 47 
cm3), average uterus (47 - 60cm3), large uterus (> 60cm3). For external os to fundus 




Table 3.4: Uterine volume and length of uterus divided according to the 30th and 70th 
centiles of measurements 
Uterine dimensions Number of patients Percentage 
Volume   
< 47 cm3 70 33.8 
47 - 60 cm3 68 32.9 
> 60 cm3 69 33.3 
Length of uterus  
 (external os to fundus) 
< 7 cm 65 34.6 
7 - 7.6 cm 55 29.3 
> 7.6 cm 68 36.2 
 
3.7 Cycle characteristics 
 
Two thirds of women required IVF treatment (65.7%; n = 92/140) with the 
remainder having ICSI treatment (34.2%; n = 38/140), with three of the male partners 
requiring testicular sperm extraction (TESE). 
The median number of oocytes retrieved at oocyte collection, over all cycles, 
was 9 with a range of 1 - 42 eggs. Almost three quarters of embryo transfers were of 
two embryos (72.1%; n = 147/204) and most frequently occurring on day 5 (56.9%; n 
= 62). In three cases three embryos were transferred but none of the women became 
pregnant. The number of embryos transferred per cycle is displayed below in figure 




Figure 3.4: The number of embryos transferred according to cycle number 
 
Almost half (47.2%; n = 67/142) of the women who commenced an IVF cycle 
had a positive HCG in their first cycle. Over all cycles the rate of positive HCG is shown 
in Figure 3.5.  
The results are broken down as follows: 
• ‘per cycle started’ - includes all women who initiated an IVF/ICSI treatment 
cycle  
• ‘per egg collection’ - includes those who achieved egg collection (this omits 
those women who had their cycle cancelled before egg collection, e.g. poor 
response to stimulation) 
• ‘per embryo transfer’ - omits those who did not have an embryo available for 




















Figure 3.5: Positive urinary HCG test per IVF cycle. 
 
3.8 Pregnancy outcome 
 
Of those women who had a positive pregnancy test 10.9% (n = 12/110) had a 
biochemical pregnancy.  
Ultrasound scans were performed at both 6 weeks and 8 weeks gestation. 
Seventy-five (76.5%; n = 75/98) were diagnosed with a singleton pregnancy on early 
pregnancy ultrasound and 23 (23.5%; n = 23/98) were diagnosed with a twin 
pregnancy. Twin pregnancy was confirmed by ultrasound scan at 6 weeks gestation, 
where two fetal heart pulsations were present and/or at 8 weeks, where two fetal 

























Figure 3.6: Summary of treatment cycle outcome according to pregnant or not 
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Of those women who became pregnant with twins, all had two embryos 
transferred, 51.8% were 37 years or older (n = 14/27). Only two of the women under 
37 years had two good quality blastocysts in their first treatment cycle and therefore 
would have fulfilled the criteria for elective single embryo transfer (eSET).  
The rate of first trimester miscarriage was 18.6% for singletons (n = 14/75). 
One singleton pregnancy resulted in a second trimester miscarriage. Four (17.4%; n 
= 4/23) twin pregnancies resulted in first trimester spontaneous reduction to 
singleton pregnancy (as confirmed at ultrasound at 8 weeks). One twin pregnancy 
resulted in a singleton livebirth following intrauterine demise of twin one at 26 weeks 
gestation.  (Figure 3.7) 
 
Figure 3.7: Pregnancy loss in all pregnancies and also according to number of fetuses. 
Note: T1 mis= First trimester miscarriage; T2 mis= Second trimester miscarriage; 
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Over three-quarters of twin pregnancies (78.2%; n = 18/23) resulted in 
livebirth of both twins with 100% resulting in livebirth of one or both twins. Singleton 




Figure 3. 8: Pregnancy outcome in all pregnancies and according to number of 
fetuses. 
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3.9 Predicting chance of conception 
 
3.9.1 Demographics and lifestyle 
The cohort was next examined to assess if demographics and lifestyle 
predicted the chance of becoming pregnant from treatment or not as displayed in 
Table 3.5. None of the interrogated demographics or lifestyle factors (including 
smoking, alcohol intake and BMI) demonstrated a significant impact on the rate of 
pregnancy. Women who had previously conceived, but miscarried, from other 
assisted reproductive treatments i.e. intrauterine insemination (IUI) or ovulation 
induction (OII) were less likely to achieve pregnancy from IVF/ICSI, than women who 



















OR (95% CI) 
P - 
value 
Age      
Under 35 years 55 (52.9) 49 (47.1) Ref  
Over 35 years 64 (51.2) 61 (48.8) 1.07 (0.64 - 1.80) 0.80 
Ethnicity     
White Irish 104 (53.1) 92 (46.9) Ref  
Any other  15 (45.5) 18 (54.5) 1.36 (0.65 - 2.84) 0.42 
Education     
University 80 (54.4) 67 (45.6) Ref  
Cert/Diploma 10 (55.6) 8 (44.4) 0.96 (0.36 - 2.56) 0.93 
Secondary level 29 (45.3) 35 (54.7) 1.44 (0.80 - 2.60) 0.22 
Previous SC1 
pregnancy 
    
No 108 (54.8) 92 (46.0) Ref  
Yes 11 (37.9) 18 (62.1) 1.92 (0.86 - 4.28) 0.11 
Previous ART 
pregnancy 
    
No 110 (54.2) 93 (45.8) Ref  
Yes 8 (34.8) 15 (65.2) 2.218 (0.90 - 5.46) 0.08 
Smoking      
No 105 (51.2) 100 (48.8) Ref  
Yes 14 (58.3) 10 (41.7) 0.75 (0.32 - 1.77) 0.51 
Alcohol     
No 25 (50.0) 25 (50.0) Ref  
Yes 94 (52.5) 85 (47.5) 0.90 (0.48 - 1.69) 0.75 
BMI (kg/m2)     
Underweight and 
healthy (< 24.9) 
78 (53.4) 68 (46.6) Ref  
Overweight and Obese 
(> 25.0) 
41 (50.0) 41 (50.0) 1.15 (0.67-1.97) 0.62 
Model I: Univariate unadjusted model.  












Biochemical markers were also assessed for their impact on the possibility of 
achieving pregnancy. The markers of ovarian reserve demonstrated significance for 
predicting the chance of becoming pregnant from treatment. Raised FSH (FSH > 11), 
which indicates reduced ovarian function, was associated with a significant reduction 
(60%) in the odds of achieving pregnancy (OR 0.4 (0.17 - 0.91); p < 0.05).  
Women with an above average antral follicle count had a two-fold increase 
chance of pregnancy (OR 2.00; 95%CI 1.02 - 3.94) compared with those women with 
a low ovarian reserve, as evidenced by AFC < 7, also a significant result (p < 0.05). The 
final marker of ovarian reserve, AMH level, showed a trend to increased chance of 
pregnancy with a higher AMH (indicating a higher ovarian reserve) but this did not 
reach significance (OR 1.8 (0.94 - 3.43) p = 0.08) (Table 3.6). 
 
3.9.3 Uterine dimensions 
The volume of the uterus and the length of the uterus were assessed, 
according to their centile group (small uteri, average uteri and large uteri) and the 
occurrence of pregnancy or not. There was no impact of uterine dimensions, as 














OR (95% CI) 
p-value 
Cycle     
1 75 (52.8) 67 (47.2) Ref  
2 32 (48.5) 34 (51.5) 1.19 (0.66 -2.13) 0.56 
3 - 5 12 (57.1) 9 (42.9) 0.84 (0.33 - 2.12) 0.71 
FSH     
≤ 10mIU/ml 94 (49.2) 97 (50.8) Ref  
≥ 11mIU/ml 22 (71.0) 9 (29.0) 0.40 (0.17 - 0.91) 0.03 
AMH     
1 - 9pmol/L 46 (59.0) 32 (41.0) Ref  
10 - 22 
pmol/L 
32 (44.4) 40 (55.6) 1.80 (0.94 - 3.43) 0.08 
> 22 pmol/l 18 (45.0) 22 (55.0) 1.76 (0.81 - 3.80) 0.15 
TSH     
≤ 2.5mU/L 90 (54.2) 76 (45.8) Ref  
≥ 2.6mU/L 18 (37.5) 30 (62.5) 1.97 (1.02 - 3.82) 0.04 
AFC     
≤ 7 34 (58.6) 24 (41.4) Ref  
8 - 12 49 (58.3) 35 (41.7) 1.01 (0.51 - 1.99) 0.97 
≥ 13 36 (41.4) 51 (58.6) 2.00 (1.02 - 3.94) 0.04 
U/S Volume     
< 47cm3 38 (54.3) 32 (45.7) Ref  
47 - 60 cm3 37 (54.4) 31 (45.6) 0.99 (0.51 - 1.94) 0.98 
> 60 cm3 34 (49.3) 35 (50.7) 1.22 (0.63 - 2.38) 0.55 
Ext os to 
fundus 
    
< 7cm 40 (61.5) 25 (38.5) Ref  
7 - 7.6cm 26 (47.3) 29 (52.7) 1.79 (0.86 - 3.70) 0.11 
> 7.6cm 37 (54.4) 31 (45.6) 1.34 (0.67 - 2.68) 0.41 






3.10 Pregnancy complications 
Overall, the rate of individual pregnancy complications was low, with 
gestational diabetes the most frequently occurring complication followed by 
intrauterine growth restriction (IUGR) as demonstrated in Table 3.7. Less than one 
third of the cohort had a pregnancy complication, as outlined (29.8%; n = 25/84). 
 
Table 3.7: Pregnancy complications 
Pregnancy complication Yes No 
Gestational Diabetes 7 (8.3) 77 (91.7) 
Pregnancy induced Htn1 1 (1.2) 83 (98.8) 
Pre-eclampsia 4 (4.8) 80 (95.2) 
IUGR2 6 (7.1) 78 (92.9) 
PPROM3 1 (1.2) 83 (98.8) 
Oligohydramnios 1 (1.2) 83 (98.8) 
Obstetric cholestasis 2 (2.4) 82 (97.6) 
Placental abruption 1 (1.2) 83 (98.8) 
Congenital abnormality 2 (2.4) 82 (97.6) 
Any of the above 25 (29.8) 59 (70.2) 
Results displayed as n (%) 
1 - Hen - hypertension, 2 - IUGR - intrauterine growth restriction, 3 - PPROM - pre-






All ongoing pregnancies were analysed for the occurrence of obstetric 
complications. Obstetric complications occurred in almost one-third of ongoing 
pregnancies (29.7%; n = 25/84). As displayed in Table 3.8, neither the demographic 































Under 35 years 23 (79.3) 6 (20.7) Ref   




White Irish 41 (71.9) 16 (28.1) ref   
Any other  6 (85.7) 1 (14.3) 0.43 (0.05 - 
3.83) 
0.48 
Education         
University 28 (71.8) 11 (28.2) Ref   
Cert/Diploma 4 (80.0) 1 (20.0) 0.64 (0.06 - 
6.35) 
0.7 





No 39 (73.6) 14 (26.4) Ref   
Yes 8 (72.7) 3 (27.3) 1.05 (0.24 - 
4.50) 
0.95 
Previous ART pregnancy         
No 40 (71.4) 16 (28.6) Ref   
Yes 6 (85.7) 1 (14.3) 0.42 (0.05 - 
3.74) 
0.43 
Smoking          
No 44 (75.9) 14 (24.1) Ref   
Yes 3 (50.0) 3 (50.0) 1.26 (0.30 - 
5.27) 
0.75 
Alcohol         
No 10 (76.9) 3 (23.1) Ref   





healthy (< 24.9) 
32 (78.0) 9 (22.0) Ref   
Overweight and Obese  
(> 25.0) 
15 (68.2) 7 (31.8) 1.66 (0.52 - 
5.31) 
0.39 
Model I: Univariate unadjusted model.  
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As displayed in Table 3.9, neither the biochemistry nor the ultrasound 
measurements performed prior to FSH stimulation was predictive for the occurrence 
of obstetric complications. 
 
Table 3.9: Odd Ratios for complications: ultrasound and biochemical markers 





OR (95% CI) 
P-
value 
Cycle     
1 28 (75.7) 9 (24.3) Ref  
2 16 (72.7) 6 (27.3) 1.17 (0.35 - 3.88) 0.80 
3 - 5 3 (60.0) 5 (40.0) 2.07 (0.30 - 14 - 44) 0.46 
FSH     
≤ 10mIU/ml 43 (75.4) 14 (24.6) Ref  
≥ 11mIU/ml 2 (50.0) 2 (50.0) 3.07 (0.40 - 23.87) 0.28 
AMH     
1 - 9pmol/L 14 (77.8) 4 (22.2) Ref  
10 - 22 pmol/L 15 (71.4) 6 (28.6) 1.40 (0.33 - 6.03) 0.65 
> 22 pmol/l 11 (78.6) 3 (21.4) 0.96 (0.18 - 5.19) 0.96 
TSH     
≤ 2.5mU/L 34 (75.6) 11 (24.4) Ref  
≥ 2.6 mud/L 12 (70.6) 5 (29.4) 1.29 (0.37 - 4.47) 0.69 
AFC     
≤ 7 5 (55.6) 4 (44.4) Ref  
8 - 12 16 (72.7) 6 (27.3) 0.47 (0.09 - 2.36) 0.36 
≥ 13 26 (78.8) 7 (21.2) 0.34 (0.07 - 1.60) 0.17 
U/S Volume     
< 47cm3 13 (72.2) 5 (27.8) Ref  
47 - 60 cm3 12 (80.0) 3 (20.0) 0.65 (0.13 - 3.33) 0.61 
> 60 cm3 20 (80.0) 5 (20.0) 0.65 (0.16 - 2.70) 0.55 
Ext os to 
fundus 
    
< 7cm 8 (66.7) 4 (33.3) Ref  
7 - 7.6cm 14 (82.4) 3 (17.6) 0.43 (0.08 - 2.42) 0.34 
> 7.6cm 16 (80.0) 4 (20.0) 0.50 (0.10 - 2.54) 0.40 




3.11 Pregnancy loss versus livebirth 
 
Those who conceived were investigated for any factors that would indicate 
the chance of a successful outcome of pregnancy, i.e. livebirth as opposed to a 
pregnancy loss.  None of the factors assessed demonstrated significance in terms of 
predicting livebirth or pregnancy loss.  
Women with a previous pregnancy from ART (but resulted in miscarriage, as 
all recruits were nulliparous according to inclusion criteria) showed a trend for higher 
chance of livebirth compared with those without, this did not reach significance 



















OR (95% CI) 
P-
value 
Age      
Under 35 years 12 (24.5) 37 (75.5) Ref  
Over 35 years 15 (24.6) 46 (75.4) 0.99 (0.41 - 2.38) 0.99 
Ethnicity     
White Irish 20 (21.7) 72 (78.3) Ref  
Any other  7 (38.9) 11 (61.1) 0.44 (0.15 - 1.27) 0.13 
Education     
University 15 (22.4) 52 (77.6) Ref  
Cert/Diploma 2 (25.0) 6 (75.0) 0.87 (0.16 - 4.74) 0.87 




    
No 26 (28.3) 66 (71.7) Ref  
Yes 1 (5.6) 17 (94.4) 1.92 (0.86 - 4.28) 0.11 
Previous ART 
pregnancy 
    
No 22 (23.7) 71 (76.3) Ref  
Yes 5 (33.3) 15 (66.7) 2.22 (0.90 - 5.46) 0.08 
Smoking      
No 25 (25.0) 75 (75.0) Ref  
Yes 2 (20.0) 8 (80.0) 1.33 (0.27 - 6.70) 0.73 
Alcohol     
No 8 (32.0) 17 (68.0) Ref  
Yes 19 (22.4) 66 (77.6) 0.90 (0.48 - 1.70) 0.75 
BMI (kg/m2)     
Underweight and 
healthy (< 24.9) 
17 (25.0) 51 (75.0) Ref  
Overweight and 
Obese (> 25.0) 
10 (24.4) 31 (75.6) 1.03 (0.42 - 2.54) 0.94 




Biochemical and ultrasound markers of fertility were examined for the cohort 
of women who conceived. Women with a normal AFC (8 - 12) had a 4-fold increased 
chance of livebirth compared to women with a reduced AFC of less than 7 (OR 4.09 
(95% CI 1.24 - 13.45); p < 0.05). Women with a high AFC (> 22) also had an almost 4 - 
fold higher chance of livebirth compared to those with reduced ovarian reserve (OR 
3.47 (95% CI 1.20 - 10.00); p < 0.05). Neither the length nor the volume of the uterus 





Table 3.11: Odd Ratios for livebirth and pregnancy loss: Ultrasound and biochemical 
markers 





OR (95% CI) 
P-value 
Cycle     
1 18 (26.9) 49 (73.1) Ref   
2 8 (23.5) 26 (76.5) 1.19 (0.46 - 3.11) 0.71 
3 - 5 1 (11.1) 8 (88.9) 2.94 (0.34 - 25.18) 0.32 
FSH     
≤ 10mIU/ml 24 (24.7) 73 (75.3) Ref  
≥ 11mIU/ml 3 (33.3) 6 (66.7) 0.66 (0.15 - 2.83) 0.57 
AMH     
1 - 9pmol/L 10 (31.3) 22 (68.8) Ref  
10 - 22 
pool/L 
8 (20.0) 32 (80.0) 1.81 (0.62 - 5.33) 0.28 
> 22 pool/l 4 (18.2) 18 (81.8) 2.05 (0.55 - 7.63) 0.29 
TSH     
≤ 2.5mU/L 18 (23.7) 58 (76.3) Ref  
≥ 2.6 mud/L 8 (26.7) 22 (73.3) 0.85 (0.33 - 2.24) 0.74 
AFC     
≤ 7 11 (45.8) 13 (54.2) Ref  
8 - 12 6 (17.1) 29 (82.9) 4.09 (1.24 - 13.45) 0.02 
≥ 13 10 (19.6) 41 (80.4) 3.47 (1.20 - 10.00) 0.02 
U/S Volume     
< 47cm3 9 (28.1) 23 (71.9) Ref   
47 - 60 cm3 9 (29.0) 22 (71.0) 1.80 (0.52 - 6.17) 0.35 
> 60 cm3 7 (20.0) 28 (80.0) 1.35 (0.42 - 4.33) 0.61 
Ext so to 
fundus 
    
< 7cm 8 (32.0) 17 (68.0) Ref  
7 - 7.6cm 6 (20.7) 23 (79.3) 0.96 (0.32 - 2.85) 0.94 
> 7.6cm 8 (25.8) 23 (74.2) 1.57 (0.51 - 4.85) 0.44 






3.12 Preterm labor 
 
The number of pregnancies that delivered preterm (delivery at ≤ 37 weeks 
gestation) was 19.3% (n = 16/63) with the number of very preterm deliveries (< 32 
weeks) 1.2% (n = 1). Twin pregnancies accounted for over two-thirds of pre-term 
deliveries (68.8%; n = 11/16).  
As there was only a small number of twin pregnancies detailed analysis of 
pregnancy outcomes amongst twins was not possible.  
 
 
Figure 3.7: Gestation at delivery (weeks) according to all livebirths and also according 






















All livebirths Singleton Both twins One twin
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There was no significant difference in the rate of pre-term delivery for women 
greater than 35 years old when compared to younger women. Demographics and 
lifestyle had no impact on the rate of pre-term delivery (Table 3.12). 






OR (95% CI) 
P-value 
Age      
Under 35 years 30 (81.1) 7 (18.9) Ref  
Over 35 years 37 (80.4) 9 (19.6) 1.04 (0.38 - 3.13) 0.94 
Ethnicity     
White Irish 59 (81.9) 13 (18.1) Ref  
Any other  8 (72.7) 3 (27.3) 1.70 (0.40 - 7.30) 0.47 
Education     
University 42 (80.8) 10 (19.2) Ref  
Cert/Diploma 4 (66.7) 2 (33.3) 2.10 (0.34 - 
13.12) 
0.43 




    
No 55 (83.3) 11 (16.7) Ref  
Yes 12 (70.6) 5 (29.4) 2.08 (0.61 - 7.11) 0.24 
Previous ART 
pregnancy 
    
No 55 (77.5) 16 (22.5) - - 
Yes 10 (100) 0 (0.0) - - 
Smoking      
No 62 (82.7) 13 (17.3) Ref  
Yes 5 (62.5) 3 (37.5) 2.02 (0.41 - 9.89) 0.39 
Alcohol     
No 15 (88.2) 2 (11.8) Ref  
Yes 52 (78.8) 14 (21.2) 2.02 (0.41 - 9.89) 0.39 
BMI (kg/m2)     
Underweight and 
healthy (< 24.9) 
38 (74.5) 13 (25.5) Ref  
Overweight and Obese 
(> 25.0) 
28 (90.3) 3 (9.7) 0.31 (0.08 - 1.20) 0.09 
Model I: Univariate unadjusted model.  
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Similarly, biochemical and ultrasound markers of fertility were not predictive of pre-
term delivery. Neither uterine dimensions nor uterine volume impacted on the rate 
of pre-term delivery with very similar distribution of pre-term deliveries in each 
































OR (95% CI) 
P-value 
Cycle     
1 40 (81.6) 9 (18.4) Ref  
2 22 (84.6) 4 (15.4) 0.81 (0.22 - 2.93) 0.75 
3 - 5 5 (62.5) 3 (37.5) 2.67 (0.54 - 13.56) 0.23 
FSH     
≤ 10mIU/ml 59 (80.8) 14 (19.20) Ref  
≥ 11mIU/ml 4 (66.7) 2 (33.3) 2.11 (0.35 - 12.70) 0.42 
AMH     
1 - 9pmol/L 16 (72.7) 6 (27.3) Ref  
10 - 22 pool/L 28 (87.5) 4 (12.5) 0.38 (0.09 - 1.56) 0.18 
> 22 pool/l 12 (66.7) 6 (33.3) 1.33 (0.34 - 5.18) 0.68 
TSH     
≤ 2.5mU/L 45 (77.6) 13 (22.4) Ref  
≥ 2.6 mud/L 20 (90.9) 29 (9.1) 0.35 (0.07 - 1.70) 0.19 
AFC     
≤ 7 9 (69.2) 4 (30.8) Ref  
8 - 12 25 (86.2) 4 (13.8) 0.36 (0.07 - 1.75) 0.21 
≥ 13 33 (80.5) 8 (19.5) 0.55 (0.13 - 2.23) 0.40 
U/S Volume     
< 47cm3 18 (78.3) 5 (21.7) Ref  
47 - 60 cm3 17 (77.3) 5 (22.7) 1.06 (0.26 - 4.32) 0.94 
> 60 cm3 23 (82.1) 5 (17.9) 0.78 (0.20 - 3.13) 0.73 
Ext so to fundus     
< 7cm 14 (82.4) 3 (17.6) Ref  
7 - 7.6cm 15 (65.2) 8 (34.8) 2.49 (0.55 - 11.31) 0.24 
> 7.6cm 19 (82.6) 4 (17.4) 0.98 (0.19 - 5.11) 0.98 




3.13 Mode of delivery 
 
Almost half of the women had a vaginal delivery (48.2%; n = 40/83) and one 
quarter had a planned caesarean section (26.5%; n = 22/83). The remainder were 
delivered by emergency caesarean section 25.3% (n = 21/83) with two thirds 
occurring intrapartum (n = 14). 
 
Figure 3.8:  Mode of delivery 
Note: SVD= spontaneous vaginal delivery; CS= Caesarean section 
 
The population was analysed to assess risk factors for caesarean delivery 
None of the demographic and lifestyle factors, including age and BMI impacted on 























Furthermore, neither fertility markers nor uterine dimensions including 
uterine volume helped determine risk of caesarean delivery versus vaginal delivery 
(Table 3.15). 
 






OR (95% CI) 
P-value 
Age      
Under 35 years 18 (48.6) 19 (51.4) Ref  
Over 35 years 21 (46.7) 24 (53.3) 1.08 (0.45 - 2.59) 0.86 
Ethnicity     
White Irish 32 (45.1) 39 (54.9) Ref  
Any other  7 (63.4) 4 (36.4) 0.47 (0.13 - 1.75) 0.26 
Education     
University 22 (43.1) 29 (56.9) Ref  
Cert/Diploma 4 (66.7) 2 (33.3) 0.38 (0.06 - 2.26) 0.29 
Secondary level 13 (52.0) 12 (48.0) 0.70 (0.27 - 1.83) 0.47 
Previous spontaneously 
conceived pregnancy 
    
No 22 (48.5) 34 (51.5) Ref  
Yes 7 (43.8) 9 (56.3) 1.21 (0.40 - 3.63) 0.73 
Previous ART pregnancy     
No 32 (45.7) 38 (54.3) Ref  
Yes 7 (70.0) 3 (30.0) 0.36 (0.09 - 1.51) 0.16 
Smoking      
No 34 (45.9) 40 (54.1) Ref  
Yes 5 (62.5) 3 (37.5) 1.13 (0.38 - 3.37) 0.83 
Alcohol     
No 8 (50.0) 8 (50.0) Ref  
Yes 31 (47.0) 35 (53.0) 1.13 (0.38 - 3.37) 0.83 
BMI (kg/m2)     
Underweight and healthy 
(< 24.9) 
27 (54.0) 23 (46.0) Ref  
Overweight and Obese (> 
25.0) 
12 (38.7) 19 (61.3) 1.86 (0.75 - 4.63) 0.18 










OR (95% CI) 
P-value 
Cycle     
1 23 (47.9) 25 (52.1) Ref  
2 12 (46.2) 14 (53.8) 1.07 (0.41 - 2.79) 0.89 
3 - 5 4 (50.0) 4 (50.0) 0.92 (0.21 - 4.11) 0.91 
FSH     
≤ 10mIU/ml 33 (45.8) 39 (54.2) Ref  
≥ 11mIU/ml 4 (66.7) 2 (33.3) 0.42 (0.07 - 2.46) 0.34 
AMH     
1 - 9pmol/L 9 (40.9) 13 (59.1) Ref  
10 - 22 pool/L 15 (48.4) 16 (51.6) 0.74 (0.25 - 2.23) 0.59 
> 22 pool/l 10 (55.6) 8 (44.4) 0.55 (0.16 - 1.95) 0.55 
TSH     
≤ 2.5mU/L 28 (49.1) 29 (50.9) Ref  
≥ 2.6 mud/L 10 (45.5) 12 (54.5) 1.16 (0.43 - 3.10) 0.77 
AFC     
≤ 7 4 (30.8) 9 (69.2) Ref  
8 - 12 16 (57.1) 12 (42.9) 0.33 (0.08 - 1.35) 0.12 
≥ 13 19 (46.3) 22 (53.7) 0.52 (0.14 - 1.94) 0.33 
U/S Volume     
< 47cm3 12 (52.2) 11 (47.8) Ref  
47 - 60 cm3 9 (42.9) 12 (57.1) 1.46 (0.44 - 4.78) 0.54 
> 60 cm3 12 (42.9) 16 (57.1) 1.46 (0.48 - 4.41) 0.51 
Ext so to fundus     
< 7cm 9 (52.9) 8 (47.1) Ref  
7 - 7.6cm 12 (54.5) 10 (45.5) 0.94 (0.26 - 3.34) 0.92 
> 7.6cm 8 (34.8) 15 (65.2) 2.11 (0.59 - 7.60) 0.25 
Model I: Univariate unadjusted model.  
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3.14 NICU Admission 
 
Overall, the rate of admission to the neonatal intensive care unit (NICU) was 
low with only 20.5% of infants (n = 17/83) requiring NICU admission.  
Maternal age greater than 35 years had a higher rate (28.3%; n = 13/46), 
although not reaching statistical significance, of an infant requiring NICU admission 
when compared with women under 35 years (10.8%; n = 4/37; p = 0.06) (Table 3.16). 











OR (95% CI) 
p -
value 
Age      
Under 35 years 33 (89.2) 4 (10.8) Ref  
Over 35 years 33 (71.7) 13 (28.3) 3.25 (0.96 - 
11.01) 
0.06 
Ethnicity     
White Irish 55 (76.4) 17 (23.6) -  - 
Any other  11 (100) 0 (0.0) - - 
Education     
University 40 (76.9) 12 (23.1) Ref  
Cert/Diploma 5 (83.3) 1 (16.7) 0.67 (0.07 - 
6.27) 
0.72 





    
No 52 (78.8) 14 (21.2) Ref  
Yes 14 (82.4) 3 (17.6) 0.80 (0.20 - 
3.16) 
0.75 
Previous ART pregnancy     
No 56 (78.9) 15 (21.1) -  - 
Yes 10 (100) 0 (0.0) - - 
Smoking      
No 63 (84.0) 12 (16.0) Ref  
Yes 3 (37.5) 5 (62.5) 5.12 (0.63 - 
41.70) 
0.13 
Alcohol     
No 16 (94.1) 1 (5.9) Ref  
Yes 50 (75.8) 16 (24.2) 5.12 (0.63 - 
41.70) 
0.13 
BMI (kg/m2)     
Underweight and 
healthy (< 24.9) 
41 (80.4) 10 (19.6) Ref  
Overweight and Obese (> 
25.0) 
25 (80.6) 6 (19.5) 0.98 (0.32 - 
3.04) 
0.98 
Model I: Univariate unadjusted model.  
134 
 







OR (95% CI) 
p-value 
Cycle     
1 38 (77.6) 11 (22.4) Ref  
2 22 (84.6) 4 (15.4) 0.63 (0.18 - 2.21) 0.47 
3 - 5 6 (75.0) 2 (25.0) 1.15 (0.20 - 6.53) 0.87 
FSH     
≤ 10mIU/ml 58 (79.5) 15 (20.5) Ref  
≥ 11mIU/ml 4 (66.7) 2 (33.3) 1.93 (0.32 - 11.6) 0.47 
AMH     
1 - 9pmol/L 17 (77.3) 5 (21.9) Ref  
10 - 
22pmol/L 
25 (78.1) 7 (21.9) 0.95 (0.26 - 3.50) 0.94 
> 22 pmol/L 15 (83.3) 3 (16.7) 0.68 (0.14 - 3.34) 0.64 
TSH     
≤ 2.5mU/L 43 (74.1) 15 (25.9) Ref  
≥ 2.6 mud/L 20 (90.9) 2 (9.1) 0.29 (0.06 - 1.38) 0.12 
AFC     
≤ 7 9 (69.2) 4 (30.8) Ref  
8 - 12 24 (82.8) 5 (17.2) 0.47 (0.10 - 2.15) 0.33 
≥ 13 33 (80.5) 8 (19.5) 0.55 (0.13 - 2.23) 0.40 
U/S Volume     
< 47cm3 19 (82.6) 4 (17.4) Ref  
47 - 60 cm3 17 (77.3) 5 (22.7) 1.40 (0.32 - 6.07) 0.66 
> 60 cm3 23 (82.1) 5 (17.9) 1.03 (0.24 - 4.40) 0.97 
Ext os to 
fundus 
    
< 7cm 15 (88.2) 2 (11.8) Ref  
7 - 7.6cm 15 (65.2) 8 (34.8) 4.00 (0.73 - 22.05) 0.11 
> 7.6cm 20 (87.0) 3 (13.0) 1.13 (0.17 - 7.60) 0.90 





There was a high rate of livebirth amongst the cohort. All twin pregnancies 
resulted in the livebirth of at least one infant (i.e. there was no pregnancy loss that 
involved both twins). Lifestyle and demographics did not significantly impact on ART 
or pregnancy outcome. Uterine dimensions had no impact on ART or pregnancy 
outcomes. Markers of ovarian reserve i.e. AMH, FSH and AFC helped determine ART 
outcome and livebirth rate. There was a low rate of twin pregnancy amongst the 
women in the cohort, in spite of almost three quarters of all embryo transfers being 
double embryo transfers. This was identified in the early stages of the study. 
Furthermore, in the retrospective study, twin pregnancies had been identified as 
having more reasonable perinatal outcomes than was originally hypothesised, 
including a very low rate (1.5%) of extreme prematurity, therefore the decision was 
made to also follow the outcome of singleton pregnancies. The cross-sectional study 
(outlined in Chapter 4) was developed to assess other factors, including stress, that 


































4.1 Methods  
 
A patient survey was distributed to all women who were recruited to the 
prospective cohort and to a randomly selected women attending Cork Fertility 
Centre for consultation or treatment. 
 
4.1.1 Background (Women’s Health Cohort study, WHC) 
The survey is a modified version of the validated survey used for the Women’s 
Health Cohort study at Cork University Maternity Hospital  (CUMH)  (217). The WHC 
study explored the following potential risk factors for miscarriage among a 
population of pregnant women attending the early pregnancy assessment unit (EPU) 
of CUMH. The women attended EPU for either a first trimester scan or for their 
routine booking scan at 12 weeks gestation. The EPU provides ultrasound scans to 
women who present with pain and/or bleeding during the first trimester of 
pregnancy. It also provides ultrasound scans to asymptomatic women who have a 
history of miscarriage. All women are offered a booking scan at 12 weeks gestation 
for dating purposes. The WHC study assessed the following areas; socioeconomic 
characteristics, past reproductive history, diet and lifestyle factors, physical activity 
and partners’ characteristics. The WHC survey was developed through a review of 
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the literature. For example, demographic questions reflected those collected by 
other national collections or census by the Central Statistics Office (CSO). Questions 
about diet and lifestyle factors were selected using the Pregnancy Risk Assessment 
Monitoring System (PRAMS), Ireland  (218). The remaining sections were not 
collected using validated questionnaires. The WHC study survey was modified for use 
in this study by including questions directly related to subfertility and where 
questions referred to pregnancy, by modification to refer to ‘trying to conceive’.  The 
survey also included information on a range of traumatic events e.g. loss of job, 
separation or divorce, serious accident or illness, death of someone close, previous 
miscarriage, stillbirth and death of a child, based on a list developed by Maconochie 
et al.  (138). Women were asked to indicate if they experienced a traumatic event in 
the last 12 months, more than 12 months ago, or not at all.  The WHC study was 
approved by the institutional Clinical Research Ethics Committee (Reference: ECM 4 
(iii) 10/01/12). 
 
4.1.2 Survey details 
The participants were invited to complete a paper based or web-based 
survey. The survey captured comprehensive demographic and lifestyle data relevant 
to the period of time they had been trying to conceive (for sample of survey see 
appendix viii) This included: 
• Ethnicity, marital status, living arrangements, education and employment status 
• Physical exercise- frequency and duration 
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• Dietary factors including caffeine intake, fruit and vegetable intake 
• Smoking and alcohol  
• Medications and illicit drug use 
• Medical conditions 
• Previous fertility and obstetric history where applicable 
• A detailed survey on emotional/psychological wellbeing to measure specifically 
o Perceived stress - 10-item perceived stress scale (PSS-10) was developed 
as part of the women’s health study to assess perceived stress.  Using a 5-
point scale ranging from never to very often, women were asked to 
indicate how often life situations were perceived as uncontrollable, 
unpredictable and stressful in the past month. Higher summary scores 
indicate greater perceived stress. 
o Emotional wellbeing -  measured using a 6-item subscale of the RAND-36  
(219). Women were asked to report how often they had felt happy, tired, 
worn out, nervous, downhearted or sad over the past four weeks. 
Responses were measured on a 6-point scale ranging from ‘none of the 
time’ (score of zero) to ‘all of the time’ (score of five). Higher summary 
scores indicate a more favourable state of emotional wellbeing. 
o Social support -  measured using the Maternity Social Support Scale  (220). 
This 6-item scale measures support from the woman’s spouse, family and 
their wider social network on a 5-point scale ranging from ‘never’ (score 
of 1) to always (score of 5).  Higher summary scores are indicating higher 
levels of social support. 
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o Outlook -  measured using the Revised Life Orientation Test  (LOT-R) which 
is a measure of dispositional optimism  (221). This 10-item scale assesses 
individual differences in generalised optimism versus pessimism. Women 
chose from a 5-point scale ranging from ‘I strongly disagree’ (score of 1) 
to ‘I strongly agree’ (score of 5).   Higher summary scores are indicative of 
an optimistic rather than a pessimistic outlook 
 
4.1.3 Distribution of survey (web-based, paper based) 
The paper-based survey was distributed at random to women attending the 
Cork Fertility Centre for consultation or treatment. The women completed the survey 
and returned it in a sealed envelope to the reception desk at the clinic. Three 
hundred fifty-six women in this cohort were invited to complete the survey and 208 
women responded, resulting in a response rate of 58.4%. Women separately 
recruited for the prospective cohort study were invited by email, following 
completion of the initial assessment and signing of the consent form, to complete a 
web-based version of the survey using the online survey software site Survey Gizmo® 
(Widgix LLC, Boulder Colorado, U.S.A). One hundred twelve women in this cohort 
completed the survey resulting in a response rate of 78.9% (n = 112/142). The 






4.1.4 Data collection  
The paper-based surveys were returned by the patient to Cork Fertility Centre 
once complete. Each woman was assigned a study identification number so that the 
results of the survey could be transcribed into and anonymised in an encrypted 
Microsoft Excel database. The outcome of treatment for those who proceeded for 
ART treatment was followed up through the electronic patient database, IDEAS V. 5.3 
™, Mellowood Medical.  The results were then transcribed into an Excel dataset for 
further analysis.  
For the women recruited for the detailed prospective study who completed 
the web-based survey, the online software collated the results which were then 
exported to a Microsoft Excel dataset, where the data was anonymised according to 
the patient’s unique study identification number. Outcomes were followed 
prospectively through the IDEAS electronic patient database. 
 
4.1.5 Outcome measurements 
The specific outcomes measured were the occurrence of pregnancy  (defined 
as positive urinary HCG test), first trimester miscarriage  (defined as loss of an 
intrauterine pregnancy at ≤ 12+6 weeks gestation), second trimester miscarriage  
(defined as loss of an intrauterine pregnancy at 13 - 23+6 weeks gestation), 
intrauterine fetal demise  (defined as a fetus with no signs of life in-utero after 24 
weeks gestation), neonatal death  (NND; defined as death in the first 28 days of life) 
and livebirth  (liveborn infant weighting ≥ 500g and/or delivered at ≥ 24 weeks 
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gestation). The occurrence of pregnancy and miscarriage was collected prospectively 
at the fertility clinic as part of the routine follow up of IVF/ICSI outcome. Livebirth 
was recorded by fertility nurses either by the woman self-reporting i.e. by the woman 
contacting the clinic or by directly contacting the women postnatally. The survey 
results of those women who became pregnant were also compared to women who 
conceived spontaneously, recruited separately as part of the Women’s Health Cohort 




The second study population was a questionnaire-based study of women 
attending the fertility clinic for consultation or treatment. In total, 320 surveys were 
completed and the results analysed according to outcome (see appendix viii for a 
sample of the survey). The specific outcome measures were the occurrence of 
pregnancy, miscarriage and livebirth. The survey results of those women who 
became pregnant were also compared to women who conceived spontaneously, 
recruited through the CUMH Women’s Health Study (WHC).  
 
4.3 Patient demographics - fertility clinic cohort 
 
Three hundred and twenty (response rate 64%; n = 320/498) women 
responded to the survey with age range of 27 - 46 years with a mean age of 36 years 
± 3.4 years. Two-thirds (64%; n = 199) were 35 years or older. Almost 90% (n = 282) 
were of white Irish ethnicity and almost 85% (n = 268) were married (Table 4.1). 
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From a lifestyle perspective, 60% (n = 183) were of normal BMI, with 38% (n 
= 116) being either overweight or obese. Only 5.8% (n = 18) were cigarette smokers.  
When characteristics were compared to the women from the Women’s 
Health Study  (WHC) there was a greater proportion of women under 35 in the latter 
group  (67.9%; n = 279 p < 0.001) and a higher number of single or co-habiting women 
in the WHC than those who attending the Cork Fertility Centre  (p < 0.001)  (Table 
4.1).  
The WHC had a lower number of women who had completed an 
undergraduate or postgraduate degree (p < 0.001) and were almost three times more 
likely to be smokers (15.8%; n = 63, p < 0.001). There was no significant difference in 
BMI between the two groups with approximately one third of both groups either 












Table 4.1: Maternal characteristics of women who attended the fertility clinic 
compared to the women’s health cohort who attended the Early Pregnancy Unit 
during the first trimester of pregnancy. 
 Fertility 
Clinic 
n = 320 
WHC 
n = 411 
p-value 
Age    < 0.001 
Under 35 years 112 (36.0) 279 (67.9)  
35 years and older 199 (64.0) 132 (32.1)  
Ethnicity   0.002 
White Irish 282 (89.3) 329 (78.9)  
Any other white background 25 (7.9) 64 (14.4)  
Other including mixed 
background 
9 (2.8) 24 (5.8)  
Marital Status   < 0.001 
Single 6 (1.9) 61 (14.6)  
Married 268 (84.5) 259 (62.1)  
Cohabitating 40 (12.6) 88 (21.2)  
Separated/Divorced/Widowed 3 (0.9) 8 (2.0)  
Education   < 0.001 
Some Primary and/or 
secondary level 
38 (12.0) 115 (17.3)  
Certificate and/or higher 
diploma 
103 (32.5) 152 (36.5)  
Undergraduate or 
postgraduate degree 
176 (55.5) 149 (35.9)  
Smoking status   < 0.001 
Smoker 18 (5.8) 63 (15.8)  
BMI (kg/m2)   0.545 
Underweight (< 18.5) 6 (2.0) 7 (1.8)  
Healthy weight (18.5 - 24.9) 183 (60.0) 248 (65.1)  
Overweight (25.0 - 29.9) 72 (23.6) 82 (21.5)  
Obese (> 30.0) 44 (14.4) 44 (11.5)  






4.4 Life stressors - fertility clinic cohort versus WHC 
 
Both groups replied to questions on stressors in the last 12 months. Both 
cohorts had high numbers reporting a stressful job. Reports of a stressful job were 
significantly more frequent amongst the fertility clinic cohort (50%; n = 160 v 40%; n 
= 167) (p < 0.05). The WHC women were more likely to report serious financial 
problems within the past 12 months (p < 0.005). The WHC had a higher proportion 
of women reporting a previous miscarriage (18.7% v 11.6%; p = 0.005) and a previous 
stillbirth (0/320 v 3/411 0.7%; p = 0.05) in the past 12 months. In both groups, one in 




Table 4.2: Reported stressful life events in the past 12 months by women attending 
the fertility clinic population and those in the women’s health cohort. 
Data presented as n (%) 
4.5 Fertility clinic cohort - treatment outcomes 
 
Of those women attending the fertility clinic, 290 (90%; n = 290/320) 
proceeded to treatment (ovulation induction, intrauterine insemination, IVF/ICSI) 
during the study period. Of those who underwent fertility treatment, 58.2% (n = 
169/290) became pregnant.  
As outlined in Table 4.3, a number of demographic and lifestyle factors were 
analysed for their impact on chance of conception.  Age 35 years or older was the 
only patient characteristic that was near significance (p = 0.051) in determining 
 Fertility 
Clinic  
WHC p - value 
Job generally demanding/stressful 160 
(50.0) 
167 (40.0) 0.028 
Loss of job/job security 26 (8.1) 25 (6.0) 0.996 
Separation/divorce 3 (0.9) 4 (1.0) 0.377 
Serious financial problems 10 (3.1) 37 (8.9) 0.003 
Accident 4 (1.3) 6 (1.4) 0.074 
Serious illness 8 (2.5) 9 (2.2) 0.756 
Serious illness of someone close 47 (14.7) 52 (12.5) 0.107 
Death of someone close 32 (10.0) 46 (11.0) 0.001 
Death of a child 0 (0.0) 1 (0.2) 0.152 
Stillbirth 0 (0.0) 3 (0.7) 0.050 
Previous miscarriage 37 (11.6) 78 (18.7) 0.005 
Another stressful/traumatic event 21 (6.6) 27 (6.5) 0.874 
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pregnant versus non-pregnant with women less than 35 years old being more likely 
to conceive.  
 
Table 4.3: Patient characteristics of women who underwent fertility treatment 
according to the occurrence or not of pregnancy 
 Pregnant Not Pregnant p-value 
Age   0.051 
Under 35 years 66 (39.1) 27 (27.3)  
35 years and older 103 (60.9) 72 (72.7)  
Ethnicity   0.637 
White Irish 151 (90.4) 88 (90.7)  
Any other white background 12 (7.2) 7 (7.2)  
Other including mixed background 4 (2.4) 2 (2.0)  
Marital Status   0.499 
Single  2 (1.2) 2 (2.0)  
Married 148 (87.6) 79 (80.6)  
Cohabitating 17 (10.1) 16 (16.3)  
Separated/Divorced/Widowed 2 (1.2) 1 (1.0)  
Education   0.162 
Some Primary and/or secondary 
level 
18 (10.7) 12 (12.2)  
Certificate and/or higher diploma 57 (33.9) 30 (30.6)  
Undergraduate or postgraduate 
degree 
93 (55.2) 56 (57.2)  
Smoking status   0.292 
Smoker 14 (8.7) 12 (12.7)  
BMI (kg/m2)   0.250 
Underweight (<18.5) 3 (1.8) 1 (1.1)  
Healthy weight (18.5 - 24.9) 95 (57.6) 63 (67.5)  
Overweight (25.0 - 29.9) 46 (27.9) 3 (17.2)  
Obese (> 30.0) 21 (12.7) 13 (14.0)  





4.6 Fertility clinic cohort - Impact of stress on conception 
 
Analysis of individual life stressors in the preceding 12 months, including job 
stress, serious financial problems, or pregnancy loss did not reveal significance in 
terms of conceiving from fertility treatment. A small number of women had 
experienced serious illness in the preceding 12 months and demonstrated 
significance in terms of not achieving pregnancy (Table 4.4). 
 
Table 4.4: Reported stressful life events amongst fertility clinic cohort. 
 Pregnant Not pregnant p-value 
Job generally demanding/stressful 83 (62.9) 56 (71.8) 0.187 
Loss of job/job security 16 (16.8) 7 (21.9) 0.523 
Separation/divorce 2 (2.4) 1 (4.0) 0.542 
Serious financial problems 5 (5.6) 2 (7.1) 0.765 
Accident 2 (2.3) 2 (7.4) 0.213 
Serious illness 3 (3.5) 4 (13.8) 0.047 
Serious illness of someone close 24.0 (24) 13 (13.3) 0.263 
Death of someone close 17 (16.2) 10 (21.3) 0.448 
Death of a child - - - 
Stillbirth - - - 
Previous miscarriage 21 (22.1) 10 (25.0) 0.715 
Another stressful/traumatic event 12 (12.6) 7 (20.0) 0.291 
Note: Categories are not mutually exclusive. 







4.7 Fertility clinic cohort - Emotional wellbeing 
 
Psychological factors were also analysed in terms of achieving pregnancy in 
those women who proceeded to fertility treatment. Overall, the group had medium 
to high rates of emotional wellbeing and this did not differ between those who 
conceived or failed to conceive from treatment. Rates of maternal social support 
were very high, 90.7% (n = 146) amongst those who conceived and 89% (n = 81) 
amongst those who failed to conceive. They had medium to low levels of perceived 
stress and average energy levels and no significance was noted in terms of achieving 
pregnancy (Table 4.5) 
 
Table 4.5: Reported psychological factors amongst fertility clinic cohort. 
 Pregnant Not pregnant p-value 
Emotional Wellbeing   0.696 
Low 44 (26.7) 27 (29.3)  
Medium 55 (33.3) 29 (31.5)  
High 66 (40.0) 36 (39.1)  
Maternal Social Support   0.954 
Low 1 (0.6) 1 (1.1)  
Medium 14 (8.7) 9 (9.9)  
High 146 (90.7) 81 (89.0)  
Energy/Fatigue   0.299 
Low  48 (29.4) 23 (24.7)  
Medium 68 (41.7) 41 (44.1)  
High 47 (28.8) 29 (31.2)  
Perceived Stress   0.393 
Low 50 (30.3) 34 (36.2)  
Medium 66 (40.0) 39 (41.5)  
High 49 (29.7) 21 (22.3)  




4.8 Fertility clinic cohort - Pregnancy outcomes 
 
The women who became pregnant from fertility treatment were further 
analysed according to livebirth and pregnancy loss. Pregnancy loss in this group 
included biochemical pregnancy and miscarriage. Almost half of the pregnant women 
(47.6%; n = 80) delivered a singleton and 23 (n = 13.7%) delivered twins.  
Women 35 years or older were more likely to suffer a miscarriage (67.9%; n = 
19) compared to women less than 35 years (32.1%; n = 9) (Table 4.6). There was no 


















Table 4.6: Maternal characteristics of women pregnant following fertility treatment 





Age    0.525 
Under 35 years 56 (40.3) 9 (32.1)  
35 years and older 83 (59.7) 19 (67.9)  
Ethnicity   0.703 
White Irish 124 (89.9) 25 (92.6)  
Any other white background 11 (8.0) 1 (3.7)  
Other including mixed 
background 
3 (2.1) 1 (3.7)  
Marital Status   0.033 
Single  2 (1.4) 0 (0.0)  
Married 124 (89.2) 23 (82.1)  
Cohabitating 13 (9.4) 3 (10.7)  
Separated/Divorced/Widowed 0 (0.0) 2 (7.2)  
Education   0.060 
Some Primary and/or secondary 
level 
13 (9.4) 5 (17.8)  
Certificate and/or higher 
diploma 
48 (34.8) 8 (28.6)  
Undergraduate or postgraduate 
degree 
77 (55.8) 15 (53.6)  
Smoking status   0.333 
Smoker 3 (2.3) 1 (3.7)  
BMI (kg/m2)   0.795 
Underweight (<18.5) 2 (1.5) 1 (3.6)  
Healthy weight (18.5 - 24.9) 79 (58.5) 15 (53.6)  
Overweight (25.0 - 29.9) 36 (26.7) 9 (32.1)  
Obese (> 30.0) 18 (13.3) 3 (10.7)  
Data presented as n (%) 





4.9 Fertility clinic cohort - Stress and pregnancy outcomes 
 
The analysis of the responses to questions on individual life stressors revealed 
a higher rate of pregnancy loss amongst those who reported a stressful/demanding 
job (p < 0.05). A number of patients reported non-specified stressful life events and 
separation/divorce in higher numbers amongst the pregnancy loss group, reaching 
statistical significance, however the numbers are small thus limiting interpretation 
(Table 4.7). 
 
 Table 4.7: Reported stressful life events amongst women pregnant from fertility 
treatment in terms of livebirth and pregnancy loss. 
 
Birth   Pregnancy 
Loss 
p-value 
Job generally demanding/stressful 37 (33.3) 11 (57.9) 0.040 
Loss of job/job security 13916.5) 3 (18.8) 0.823 
Separation/divorce 0 (0) 2 (13.3) 0.002 
Serious financial problems 3 (4.1) 1 (7.1) 0.611 
Accident 1 (1.4) 1 (7.1) 0.191 
Serious illness 3 (4.2) 0 (0.0) 0.454 
Serious illness of someone close 19 (22.9) 5 (31.3) 0.475 
Death of someone close 13 (14.8) 4 (25.0) 0.309 
Death of a child - - - 
Stillbirth - - - 
Previous miscarriage 16 (20.3) 5 (31.3) 0.334 
Another stressful/traumatic event 6 (7.8) 6 (35.3) 0.002 
Note: Categories are not mutually exclusive. 




4.10 Psychological factors and pregnancy outcomes 
 
Psychological factors had no impact on the risk of pregnancy loss amongst the 
group. Those who achieved livebirth were less likely to have higher perceived stress. 
All women had high levels of maternal support (Table 4.8). 
Table 4.8: Reported psychological factors amongst women pregnant from fertility 
treatment in terms of livebirth and pregnancy loss. 
 Birth Pregnancy 
Loss 
 
Emotional Wellbeing   0.413 
Low 38 (28.1) 5 (17.9)  
Medium 43 (31.9) 12 (42.9)  
High 54 (40.0) 11 (39.3)  
Maternal Social 
Support 
  0.883 
Low 1 (0.8) 0 (0.0)  
Medium 12 (9.0) 2 (7.7)  
High 120 (90.2) 24 (92.3)  
Energy/Fatigue   0.646 
Low 39 (29.1) 8 (29.6)  
Medium 54 (40.3) 13 (48.1)  
High 41 (30.6) 6 (22.2)  
Perceived Stress   0.122 
Low 44 (32.6) 6 (21.4)  
Medium 49 (36.3) 16 (57.1)  
High 42 (31.3) 6 (21.4)  
Data presented as n (%) 
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There were variations between the two groups in terms of demographics and 
lifestyle. However advanced maternal age (≥ 35 years) was the only characteristic 
that was near significance in terms of determining conception. 
Stress did not demonstrate an impact on the chance of conceiving, apart from 
the small number who reported recent serious illness. The women generally reported 
high rates of emotional wellbeing.  
Amongst the fertility cohort stress, particularly job-related stress, is 
associated with higher chance of pregnancy loss. Conversely, those who achieve 




There are some demographic and lifestyle differences between the fertility 
clinic cohort and the WHC, reflective of the populations studied. Amongst the fertility 
clinic cohort, overall, the women reported good emotional wellbeing and support. 
However, pregnancy loss was found to be higher amongst women with stressful or 
demanding jobs and those who reported non-specified stress and 



































The demand for Assisted Reproductive Technologies  (ART), particularly 
IVF/ICSI, is increasing, mainly due to the increasing age profile of women pursuing 
pregnancy for the first time  (1, 223). The technology behind these treatments is 
evolving in the continued pursuit of higher live birth rates, in the large part, driven 
by commercial gain. In the face of increasing commercialism in ART and the drive for 
increasing success rates, it is important to maintain a focus on the aim of delivering 
a healthy mother and a term infant. 
The aetiology of subfertility is quite heterogenous with both a male and 
female partner to consider and multiple individual factors  (10). It is therefore often 
difficult to identify specific factors that may impact on conception rates and obstetric 
outcome. 
The thesis originally focussed on predicting the outcome of multiple 
pregnancies conceived following IVF/ICSI. The original hypothesis was, due to the 
increased risk of preterm labour associated with multiple pregnancies, if a woman 
could be identified prior to IVF/ICSI treatment as being at high risk of preterm labour 
then she would be selected for an elective single embryo transfer. Conversely, if a 
woman was deemed low risk for preterm labour than it may be more reasonable to 
consider a double embryo transfer, allowing for a more individualised embryo 
transfer policy tailored to the risk profile of the woman.  
The secondary aims were to identify pre-existing characteristics that may be 
associated with negative treatment outcome and adverse pregnancy outcome. This 
thesis was a broad assessment of multiple maternal characteristics including 
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physical, lifestyle, emotional/psychological, biochemical and ultrasound 
characteristics that may impact on IVF/ICSI success and subsequent pregnancy 
outcome. 
The retrospective study, outlined on Chapter 2 found that both singletons and 
twins conceived through IVF/ICSI generally have good obstetric and perinatal 
outcomes. DCDA twins conceived by ART were more likely to be delivered at 
moderate pre-term gestations than spontaneously conceived twins. However, the 
rate of extreme pre-term delivery (< 28 weeks gestation), associated with the highest 
rate of neonatal morbidity and mortality, was in fact very low amongst both twins 
and singletons, including singletons originating from a twin pregnancy (VTS 
singletons). VTS singletons were found to have favourable outcomes with a high rate 
of term delivery and all infants liveborn. They were, however, more likely to be 
delivered by caesarean section than singletons.  
The findings of the retrospective study were used to inform the direction of 
the thesis, in particular the prospective cohort study, which was then expanded to 
examine the outcomes of both singletons and multiples. 
In the prospective cohort study of nulliparous women attending for IVF/ICSI 
treatment, 2D and 3D ultrasound was used to measure the dimensions of uterine 
length and 3D measurements of uterine volume. The study found no association 
between uterine dimensions, including uterine volume on conceptions rates, 
miscarriage rates and in particular on pre-term delivery rates. The study also 
examined other factors, including lifestyle and demographics and biochemical 
markers that may impact on treatment outcome or pregnancy outcomes. Not 
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surprisingly, women 35 years and older had a higher rate of miscarriage. The 
traditional markers of diminished ovarian reserve- raised FSH level and/or decreased 
antral follicle count was associated with lower chance of pregnancy and livebirth. 
Women with an average or high antral follicle count had a significantly higher rate of 
livebirth. The more recent introduction of AMH as a biochemical marker of ovarian 
reserve did not, however, show as robust an association with pregnancy rates and 
livebirth rates. Once pregnant, a history of diminished ovarian reserve did not confer 
excess obstetric risk. 
Subclinical hypothyroidism at initial consultation was associated with a 
significantly higher rate of conception, most likely due to treatment with 
levothyroxine in order to maintain thyroid stimulating hormone (TSH) at < 2.5mU/l.  
The thesis was further expanded with a focus on other factors that affect the 
wider ART population. The cross-sectional study assessed factors including 
psychological stress and emotional wellbeing that are more difficult to elucidate but 
may have an impact on ART and pregnancy outcome. It found that the women were 
well supported emotionally. Interestingly the study found that women who reported 
a stressful or demanding job in the last 12 months had higher rates of miscarriage as 







ART conceived pregnancy 
Twin pregnancy is known to carry increased risks for both mother and fetuses. 
For the mother there is an increased risk of miscarriage, gestational hypertension 
and operative delivery. Maternal mortality is 2.5 times greater with a twin pregnancy  
(224). For the infants, most of the morbidity and mortality is associated with 
prematurity and lower birth weight. Approximately half of twins are born pre-term 
and 10% are born at less than 32 weeks gestation, compared with 1% of singletons. 
Perinatal mortality is 7 times higher for twins as compared with singletons and they 
have a ten-fold increased risk of admission to neonatal unit, with a six- fold increased 
rate of cerebral palsy. One in 12 multiple pregnancies end in death or disability of 
one or more babies  (22, 224). 
ART is known to result in increased rates of twin and higher order multiple 
(HOM) pregnancies. The rate of HOM pregnancies has dropped significantly, as has, 
to a lesser extent, the twin pregnancy rate, following guidance from several 
international regulatory committees advising clinics to increase their rates of elective 
single embryo transfer in order to avoid multiple pregnancy. In the UK the percentage 
of multiple pregnancies has dropped from just over 25% in 2008 to 11% in 2016, with 
many clinics achieving the target of less than 10%, as set by the Human Fertilisation 
and Embryology Authority’s  (HFEA) ‘One child at a time’ report 2006  (22, 224). In 
Ireland, in the absence of a national governing body and mandatory reporting of 
treatment cycle outcomes by fertility clinics, it is difficult to establish the true rate of 
multiple pregnancy arising from ART. Some, but not all, of the IVF clinics in Ireland 
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report to the European register compiled by ESHRE and these numbers indicate a 
decreasing rate for twin livebirths following IVF treatment  (223). 
 
The Retrospective study - A retrospective study of all twin and singleton 
pregnancies arising from IVF/ICSI treatment at Cork Fertility Centre 
As part of this thesis, a detailed retrospective study was performed to assess 
the outcome of dichorionic diamniotic (DCDA) twin pregnancies conceived by ART 
(ART twins) over the period (2009 - 2012). DCDA twins were selected as they are the 
twins that result from two embryos being transferred and as such ART clinicians have 
control over the rate of DCDA twins resulting from ART - iatrogenic twinning. The aim 
was to assess the obstetric outcomes of IVF/ICSI conceived twin pregnancy in our 
population and to ascertain whether ART conceived twins had excess risks when 
compared to spontaneously conceived  twins  (5). As discussed above, twin 
pregnancy carries increased obstetric and perinatal risks but there are conflicting 
reports on whether assisted conception further increases these risks when compared 
to spontaneously conceived pregnancies with some studies reporting an increased 
risk of low birth weight, preterm birth  (5 - 9) whereas other studies report no 
increased maternal or perinatal risk conferred by mode of conception.  (10 - 13) One 
systematic review by Helmerhorst et al perinatal mortality in twins conceived using 
ART was 40% lower compared with spontaneously conceived twins  (176). 
Overall, the study found that twin pregnancies conceived through ART have 
similar outcomes to spontaneously conceived twin pregnancies. Twin pregnancy 
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itself resulted in a higher rate of pre-term delivery (51.3% spontaneously conceived 
v 49% ART, p = .879) irrespective of mode of conception. Twins conceived following 
ART were more likely to be delivered by caesarean section and had a higher rate of 
delivery at moderately preterm gestations (32 - 33+6 weeks) with an associated 
higher rate of RDS and neonatal hypoglycaemia. Importantly, in terms of severe 
neonatal morbidity, there was low (< 1.5%) and similar rates of extreme pre-term 
delivery (< 28 weeks gestation) amongst both ART and spontaneously conceived 
twins. All other perinatal outcome measures were comparable between the 
conception groups and there was no difference in perinatal mortality. Maternal 
outcomes were also similar with no increased risk of antenatal complications 
conferred by ART conception.  
There is evidence that ART singletons have increased perinatal risks when 
compared to spontaneously conceived singletons, with reports of increased rates of 
pre-term delivery, low birth-weight and cerebral palsy even following adjustment for 
factors such as maternal age and parity  (176, 199). The reasons for the increased 
adverse outcomes are poorly understood. Many studies have suggested that the 
underlying subfertility or indeed that the IVF/ICSI laboratory processes may be a risk 
factor with studies showing higher rates of adverse outcomes associated with 
increasing duration of involuntary childlessness  (225). 
Vanishing twin syndrome has been identified as a potential risk factor for 
obstetric complications, in particular pre-term delivery and low birthweight. 
Vanishing twin syndrome (VTS) affects between 10 - 30% of pregnancies following 
ART  (206, 209, 226). VTS is the phenomenon whereby more than one gestational sac 
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is present on early ultrasound but due to loss or the second sac/fetus, the pregnancy 
continues as a singleton. Several studies have demonstrated an increased rate of 
adverse perinatal outcome for VTS singletons. A recent large study of 113,784 
livebirths from fresh and frozen ART cycles in the UK, by Kamath et al 2018 
demonstrated an increased risk of pre-term birth and low birthweight among VTS 
singletons when compared to singletons with only one gestational sac at early 
ultrasound  (irrespective of whether single or double embryo transfer had occurred)  
(208). 
The retrospective review was expanded from the original review of DCDA 
twins (2009 - 2012) to include all singletons and all DCDA twins conceived from ART 
at the fertility clinic (2002 - 2013). Less data was available on perinatal outcomes in 
these cohorts and no spontaneously conceived cohort of singletons or DCDA twins 
was available for comparison. The available data was limited to gestation at delivery, 
mode of delivery, birth weight and gender.  
Almost three quarters of all pregnancies conceived during the time period 
studied were singleton, with 13.6% twin pregnancies and the remainder being 
biochemical pregnancies. The women who conceived a twin pregnancy were slightly 
older than those who conceived a singleton pregnancy. This may reflect the increased 
rate of double embryo transfer in older women. Elective single embryo transfer is 
practiced for women under 37 years of age with good quality blastocysts for 
selection. It may also reflect the likelihood that older women, due to diminishing 
oocyte numbers and quality, may require more than one IVF treatment cycle, and 
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the tendency to transfer more than one embryo if previous cycles have been 
unsuccessful.   
Overall, the singleton pregnancy outcome was favourable. There was a high 
rate of livebirth (80.2%) with a vaginal delivery rate of 54.3% and a term delivery rate 
of 93.5%. Four neonatal deaths occurred. Not surprisingly, singletons were more 
likely to be delivered at term than twins. Twins were four times more likely to be 
delivered before 36 weeks gestation and have a higher rate of NNU admission. Twin 
pregnancy was more likely to result in miscarriage of one or both twins when 
compared with singleton pregnancy (34.4% v 19.4%).  
Twin pregnancy outcomes however were favourable overall, with the 
majority of twins (88%) delivered at term or late pre-term gestation (34 - 36+6). One 
third of twins were delivered by vaginal delivery. Almost 9 in 10 twin pregnancies 
resulted in livebirth of one or both twins. Almost half (47.2%) of twin pregnancies 
resulted in livebirth of both twins. There was a high rate of vanishing twin syndrome 
(VTS), higher than the rates quoted in the literature and occurred most commonly 
due to first trimester miscarriage.  
In our group of VTS singletons, all infants were liveborn with almost all 
delivered at term (93.1%). In contrast to many studies VTS singletons in the study 
group had similarly high rates of term delivery and birthweights as singletons. When 
compared with singletons, VTS singletons were more likely to be delivered by 
caesarean section (both emergency or elective, p < 0.05).  
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What is lacking from the retrospective review is the comparison of outcomes 
between the ART singletons and a similar group of spontaneously conceived 
singletons. This would aid in determining whether ART itself has an impact on 
singleton outcome.  
The prospective cohort study - A prospective study of nulliparous women after 
attending for IVF/ICSI treatment at Cork Fertility Centre  
One hundred and forty-two nulliparous women undergoing an IVF/ICSI cycle 
were recruited for the prospective study. The majority were undergoing IVF/ICSI due 
to diminished ovarian reserve. Three quarters of women had a positive pregnancy 
test, with ten percent resulting in a biochemical pregnancy. Of those women with 
ongoing pregnancies, approximately three quarters were singleton pregnancies and 
one-quarter were twin pregnancies.  
Almost one-fifth (18.6%) of singleton pregnancies resulted in a first trimester 
miscarriage. As regards twin pregnancies, none of them resulted in a first trimester 
miscarriage of both twins. Four twin pregnancies had a spontaneous reduction of one 
twin (VTS) due to first trimester miscarriage and a further one resulted in VTS due to 
IUD at 26 weeks gestation, all resulting in a singleton livebirth.  
Overall, the livebirth rate for both singletons and twins was high- all twin 
pregnancies resulted on a livebirth of at least one twin and 80% of singleton 
pregnancies resulted in a livebirth. 
In terms of demographics, physical characteristics and lifestyle the group was 
very homogenous, largely owing to the fact that they were undergoing treatment at 
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a privately funded fertility clinic and were therefore required to self-fund their 
treatment as, in Ireland, there is no state-funded IVF/ICSI treatment. Reflecting 
increasing rates of subfertility with increasing age (related to diminishing ovarian 
reserve) the mean age of the women was 35.27 years. Interestingly, while the vast 
majority of women (90%) were non-smokers, over three quarters of women 
continued to drink alcohol while trying to conceive, the majority drinking more than 
5 units of alcohol per week. However, neither cigarette smoking nor drinking alcohol 
was shown to impact on treatment or pregnancy outcomes.  
Again, reflective of the population being studied, the majority (59.8%) had a 
lower antral follicle count and the most common aetiology was diminished ovarian 
reserve. Over 85% of women however, had a normal FSH level (≤ 10mIU/ml). Not 
surprisingly, those women with a raised FSH (≥ 11mIU/ml) had significantly reduced 
chances of achieving pregnancy (OR 0.4). In contrast, those women with an average 
antral follicle count (8 - 12 antral follicles) had a two-fold increased chance of 
achieving pregnancy.  
There was a high rate (approximately 75%) of double embryo transfers over 
all cycles. The resultant twin pregnancy rate was 23.5% (n = 23). This twin pregnancy 
rate is higher than the HFEA ‘One at a Time’ aim of 10%  (22). Cork Fertility Centre 
practices elective single embryo transfer  (eSET) for women who are less than 37 
years old with more than one good quality embryo available for transfer, this is in 
accordance with NICE guidance  (18). In this instance, it is recommended that one 
embryo is selected for transfer and the remaining embryo (s) are cryopreserved for 
future use, with little impact on IVF success (when cumulative pregnancy rates from 
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the subsequent transfer of a frozen embryo as measured), and a reduction in 
iatrogenic twinning. Indeed, due to improving livebirth rates from cryopreserved 
embryos, there is increasing evidence to support eSET in women older than 37 years  
(3, 227). In the cohort of patients studied, only two women who had a double embryo 
transfer would have fulfilled the criteria for eSET therefore most double embryo 
transfers were appropriate. 
The initial focus of the study was the assessment of the uterine cavity using 
2D and 3D ultrasound to assess whether the volume of the uterus could predict the 
chance of preterm delivery, particularly in twin pregnancy. It was hypothesised that 
preterm delivery is associated with poorer neonatal outcomes and occurs more 
frequently in twin pregnancy, therefore, if a patient could be identified, in advance 
of her IVF/ICSI cycle, as being at lower risk of preterm delivery then she could be 
selected for double embryo transfer.  
As the retrospective review of twin pregnancy outcomes progressed, it 
transpired that ART conceived twins had a higher rate of moderate pre-term delivery 
(32 - 33+6 weeks gestation) but overall pregnancy outcomes were still favourable. Out 
of the large cohort reviewed, the numbers of ART conceived twins, and indeed 
singletons, that delivered at extreme prematurity  (< 28 weeks gestation) were very 
small, comprising only 9 twin infants  (6 twins  (1.9%; n = 6/316), 1 VTS singleton  
(0.8%; n = 1/133) and 2 singletons  (0.1%; n = 2/1389)).  
Furthermore, there are limitations of assessing the size of the uterine cavity 
in a non-pregnant woman. The identification of the internal cervical os on ultrasound 
of a non-gravid uterus proved difficult. Following the interrogation of the literature, 
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we identified one group who described how they identified the internal os ‘The upper 
limit of the cervix was arbitrarily defined as a plane perpendicular to the cervical 
canal positioned at the inferior limit of the endometrial line’ in their study on cervical 
length after LLETZ  (215). During the literature review we identified one study by 
Fanchin et al  (published oral abstract only) who reported on 79 women who 
underwent hysterosonometry  (the measurement of the dimensions of the uterus 
from the external os to the fundus using 2D ultrasound techniques)  (228). The group 
was divided according the 30th and 70th centile for size and the impact of the uterine 
dimensions was on the gestational age at delivery, severe pre-term delivery (< 32 
weeks) and fetal mortality. All three outcomes were significantly more prevalent 
amongst women in the group with the smallest uteri (< 63mm).  
Our population had both 2D ultrasound dimensions performed (external os 
to uterine fundus) and 3D ultrasound volume measurement of the uterus performed. 
The group were also divided according to the 30th and 70th centile for size and all 
outcome measures were studied according to this. There was no correlation found 
between uterine dimensions (both 2D and 3D) and any of the outcome measures. In 
particular, uterine dimensions had no impact on preterm delivery rates nor on any 
mode of delivery. The numbers of twin pregnancies, particularly those that delivered 
preterm, were too small to assess the impact on preterm delivery as a separate 
cohort. 
When assessing predictors for conception from treatment neither lifestyle 
nor demographics were significant, which may be due to the homogeneity of the 
study group. Previous miscarriage from intrauterine insemination/ovulation 
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induction treatment was associated with lower pregnancy rates. Although not 
reaching statistical significance and small numbers of women, it may be reflective of 
diminishing egg quality in those women. Kupka et al found that one previous 
miscarriage had a positive effect on pregnancy rates but the reverse was seen with 
increasing numbers of prior miscarriage  (229).  
Interestingly, women in this study with subclinical hypothyroidism, a high TSH 
(> 2.5mU/l) but normal T4 at initial work up, had a two-fold increased rate of 
conception. The majority of those women were treated with levothyroxine with the 
aim of maintaining TSH levels at ≤ 2.5mU/l. There is evidence that suggests that 
women with subclinical hypothyroidism undergoing IVF/ICSI who are treated with 
levothyroxine have higher pregnancy rates. There is a higher rate of subclinical 
hypothyroidism in the subfertile population as compared to that of the general 
population  (230). It is generally accepted that women planning pregnancy and 
pregnant women with subclinical hypothyroidism be treated with levothyroxine to 
reduce the risk of miscarriage in particular  (231). There have been some studies that 
have also shown an improvement in pregnancy rates following levothyroxine 
treatment in women with subclinical hypothyroidism undergoing IVF/ICSI  (232). 
More recent systematic reviews and meta-analyses show conflicting results as 
regards pregnancy rates but consensus on the reduction in the rate of miscarriage  
(233, 234). 
Given that the cohort was, on average, of advanced maternal age (35 years 
or older), there was a low rate of obstetric complications amongst the group. 
Gestational diabetes was the more frequent complication and occurred more often 
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in women over 35 years of age, as might be expected but surprisingly there was no 
difference in BMI or history of PCOS in these women.  
 
Once pregnant, a history of diminished ovarian reserve (high FSH, low AFC) 
was not predictive of obstetric complications. Markers for ovarian reserve, as would 
be expected, help predict the chance of pregnancy. Women with normal and high 
AFC had a two- and four- fold increased chance of livebirth respectively. Although 
the numbers are extremely small, thus limiting interpretation, there are similar 
findings in larger studies  (235, 236). AMH did not show the same ability to predict 
pregnancy in our study. A meta-analysis by Tal et al assessed the utility of AMH in 
predicting IVF/ICSI outcome and demonstrated a weak association between AMH 
levels and pregnancy rates and livebirth rates with another review by Iliodromiti 
drawing similar conclusions  (237, 238). 
 
The cross-sectional study - A survey-based prospective study of women attending 
for fertility consultation or treatment at Cork Fertility Centre  
There is much focus in the medical literature on the impact of lifestyle on the 
outcome of ART. Negative predictors of outcome include alcohol, smoking and 
obesity. Psychological and emotional stress has also been studied in ART patients. 
ART is known to be a stressful time for women, coping with their subfertility and the 
expectations of fertility treatments. There is no clear consensus in the medical 
literature on the impact of stress in IVF/ICSI outcome. This is most likely due to the 
heterogeneity of studies in terms of the type of stressor/stress/distress being 
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measured. The stress process is generally made up of three aspects: a stressor e.g. a 
life event, followed by the perception of stress, which then may lead to affective, 
behavioural and/or biological stress responses  (i.e. distress)  (239). Furthermore, 
there is much heterogeneity in the reporting of the outcome of assisted reproductive 
treatment.  Many studies on ART outcome will report their findings according to the 
occurrence of a positive pregnancy test, some report the rate of ‘clinical pregnancy’ 
and some report the rate of livebirth. The definition for clinical pregnancy can vary 
from the presence of an intrauterine growth sac (irrespective of the presence of a 
fetal pole), to the presence of a fetal heart pulsation at 8 weeks gestation. This limits 
the interpretation of their results and the significance of what is deemed a successful 
outcome. The majority of studies show no clear association between stress and 
conception rates from ART including a large meta-analysis by Boivin et al which also 
determined there was no causal effect between pre-treatment stress in IVF/ICSI and 
treatment outcomes  (134, 137). There are several studies however which have 
demonstrated an association with poorer outcome  (133, 136). There is a more 
robust association between psychological stress and an increased rate of miscarriage, 
irrespective of mode of conception  (7, 240). 
In order to identify determinants of successful ART treatment women were 
invited to complete a comprehensive, validated questionnaire to collect data on 
demographics, lifestyle and emotional factors that may impact on the outcome of 
the treatment cycle or obstetric outcome. 
The subfertility group, by the very fact of attending a privately-funded fertility 
clinic, was quite homogenous in terms of ethnicity, socio economic group and level 
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of education. No state-funded IVF clinic exists in Ireland that would allow the 
inclusion of a more heterogenous patient group. This group was compared to the 
Women’s Health Cohort (WHC) which comprised women attending the Early 
Pregnancy Unit (EPU) in a state funded tertiary maternity hospital. Therefore, there 
were differences between the two populations in terms of smoking status, level of 
education and marriage rates. The subfertility group were older which may be 
implicated in the aetiology of their subfertility. The WHC were more likely to have a 
history of pregnancy loss. The EPU provides reassurance scans to women who have 
a history of pregnancy loss so this most likely explains this finding, rather than it being 
representative of women with no subfertility issues. 
The cohort of subfertile women were surveyed on varying stressors and the 
impact on conception and miscarriage rates. Overall, the women were well 
supported and had good rates of emotional wellbeing. As regards the impact of 
stressors on conception rates, the small number of women who reported serious 
illness in the past 12 months were less likely to conceive. Once pregnant, women 
who reported stressful or demanding jobs, non-specified stressful life events and 
separation/divorce had a higher rate of pregnancy loss. This finding is supported by 
similar findings in the literature as discussed above. Women who achieved livebirth 
were less likely to have high rates of perceived stress. Unfortunately, the 
interpretation of this data is limited by the very small numbers but it suggests that 
stressors do not impact greatly on the chance of conception from ART but may be 




Strengths and limitations  
There are several strengths to the study. These include: the prospective 
nature of the recruitment and follow up, including ultrasound images taken at the 
time of recruitment and in advance of commencing FSH stimulation. The 
retrospective review of both singleton and twin pregnancy and a more in-depth 
retrospective review of the twin pregnancy outcomes, compared with spontaneously 
conceived twin pregnancies helped inform the outcomes in the local population. It 
highlighted the positive outcomes of IVF/ICSI twin pregnancies. 
The limitations have to be acknowledged. In the retrospective study, the 
review of singleton pregnancy outcomes was lacking complete data on parity and 
there was a relatively high number of missing data for gestation and mode of 
delivery. The cohort is also missing a spontaneously conceived control group for 
comparison.  
The initial aim of the thesis was to assess the dimensions of the uterus with 
the hypothesis that smaller uteri would carry a higher risk of pre-term delivery, 
particularly in twin pregnancy. Therefore, by identifying those women with smaller 
uteri and avoiding iatrogenic twinning for them, a more selective eSET policy, tailored 
to risk, could be used, rather than a blanket eSET policy based on age and embryo 
quality. With the exception of one study on hysterosonometry by Fanchin et al, 
published only as an oral abstract, there was no prior studies on this area. 
Furthermore, it was only as the project evolved that we realised the difficulty of 
assessing the non-pregnant uterus due to the difficulty identifying the internal os, as 




The recruitment process was slow and it was specialised, therefore it was 
initially only one researcher who could perform a 3D ultrasound assessment of the 
uterus and there was only one ultrasound machine equipped with 3D technology that 
was only available on certain days. Furthermore, numbers recruited were not 
consistent across the study time period due to my leave of absence. Two fertility 
nurse specialists were trained to continue recruiting in my absence, however, due to 
the constraints of also running a busy ultrasound scanning list while recruiting, the 
number of women recruited in that period was low. These factors impacted on 
numbers recruited. 
The unpredictability of cycle success (IVF treatment carries approximately a 
38% livebirth rate at Cork Fertility Centre) led to a longer follow up time in order to 
allow the assessment of outcomes of further treatment cycles so that more 
pregnancies could be captured.  
Initially it was hoped that the numbers of twin pregnancies would be much 
higher to allow for a separate analysis of twin pregnancy outcomes. The difficulty is 
the low rate of twin pregnancy resulting from IVF/ICSI and no ability to predict which 
patient will have a twin pregnancy, or indeed get pregnant, from treatment, in a clinic 
with almost 800 IVF/ICSI cycles per year. Therefore, in order to recruit the maximum 
number of twin pregnancies, it would have been necessary to recruit almost all 
nulliparous women coming through the clinic for treatment and due to the 
constraints described above, in particular the access to the 3D equipped ultrasound 
machine, this was not feasible. 
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Overall, a low number of pregnancies was the result with limitations on 
interpreting the data. In particular the number of twin pregnancies in the recruited 
cohort was extremely low, meaning that no meaningful separate analysis on twin 
pregnancy outcomes could be performed.  
The study group was very homogenous and not reflective of the general 
population, owing to the fact that they were required to self-fund their fertility 
treatment. As there is no state-funded IVF/ICSI treatment available in Ireland, there 
was no option to expand the study to include a more diverse population. 
 
Future Work 
Reflecting on the methods, results and limitations of the study, I feel that 
there are several things that could have been done differently and several areas that 
warrant future work. 
Certainly, a larger cohort of patients in the prospective cohort study of 
IVF/ICSI outcome may have yielded more significant findings. A larger cohort may 
have resulted in more twin pregnancies in the study, allowing for a separate analysis 
of twin outcomes, thus fulfilling the original objective of the study. 
The twin outcomes as demonstrated in the retrospective study were 
reassuring however. Certainly, it is not to be disputed that a twin pregnancy 
(irrespective of mode of conception) carries excess obstetric risk as compared to a 
singleton pregnancy but it is reassuring that ART conception does not escalate this 
risk significantly further. There are some authors now suggesting that the original 
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risks attributed to IVF conceived twins have been over-inflated, and that, coupled 
with the increased adverse outcomes associated with IVF/ICSI conceived singleton 
pregnancy, a blanket eSET policy is in fact not warranted. (241) Perhaps the focus 
should not be on avoiding twins at all cost in IVF/ICSI with a blanket eSET policy based 
on age, but to avoid twins in the higher-risk woman e.g. advanced maternal age, 
medical co-morbidities, obesity, previous pre-term labour, older women using donor 
oocytes.  
Thus, upon reflection, perhaps the thesis would be more representative of 
the population as a whole and more likely to capture the higher-risk woman, if it 
included multiparous women, women with pre-existing medical co-morbidities and 
women attending state-funded fertility treatment. Currently, there is no state-
funded IVF in Ireland resulting in a large population of subfertile couples who cannot 
afford to self-fund IVF treatment. Ideally, future work would involve incorporating 
both private and state-funded IVF clinics in order to study a more heterogenous 
group of patients. The population in this study was very homogenous in terms of 
demographics i.e. almost all white Irish, well-educated and non-smokers. 
The cross-sectional study found a link between stress peri-conceptually and 
first-trimester miscarriage and similar findings have been published in the literature. 
Unfortunately, the associations between particular stressors and lower conception 
rates or first trimester miscarriage could not be confidently interpreted as the 
number of women in the cohort was too small. A larger, prospective study may yield 
interesting results and is worthy of future work. There is certainly a role for further 
176 
 
studies on stress peri-conceptually and the outcome of pregnancy in terms of first 
trimester miscarriage.  
 
Conclusion 
The thesis as a whole has demonstrated favourable outcomes for both twin 
and singleton pregnancies conceived through IVF/ICSI. Interestingly, in spite of the 
frequently acknowledged stressors associated with undergoing ART, there was no 
indication of an impact on pregnancy rates. There was a suggestion, supported by 
the literature, that stress impacted on miscarriage rates however, which may warrant 
further investigation with larger numbers and consideration of stress management 
strategies. Uterine dimensions had no impact on the success of a treatment cycle nor 
on pregnancy outcome.  
It can be concluded that twin pregnancy outcomes from IVF/ICSI are not 
dissimilar to those of spontaneously conceived twins. However, twin pregnancies, 
irrespective of mode of conception, are associated with higher rates of pre-term 
delivery and NICU admission.  
During ART there is an element of control over the number of embryos being 
transferred and the resultant rate of twin pregnancy. Therefore, in the absence of 
any robust predictors of successful, or indeed adverse, outcome it is preferable to 
aim for single embryo transfer and a singleton pregnancy.  Couples with two good 
quality embryos should be counselled regarding the increased risk of iatrogenic 
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Appendix ii - Clinical Research Ethics Committee Approval for amendment to 







Appendix iii – Cork University Maternity Hospital Twins Database 
 
Variable  Description Variable Values 





MATERNAL_AGE Maternal age in 
years at booking 
Integer  
PARITY Parity  Categorical Nulliparous 
Multiparous 
Conception How this pregnancy 
was conceived  
Categorical  Spontaneous  
Artificial 
reproduction  
Mode of ART If artificial 
reproduction 
technology was 
used, which mode 
was used 







Chronicity  Chronicity of the 
multiples 




PRENATAL_STEROIDS Were prenatal 
steroids 
administered in this 
pregnancy  
Categorical  Yes 
No  
Unknown 
GESTDM Gestational diabetes 











OBSTETRIC_CHOLESTASIS Was obstetric 
cholestatsis 





T2 MISCARRIAGE Did the pregnancy 






IUD Did the pregnancy 







PTD Did the pregnancy 





PTD_ONSET Onset of labour for 







No trial of labour 
DELIVERY_GESTATION Gestation of 
delivery 
Categorical < 28 
28-32 
32+1 – 33+6 
34-36+6 
> 37 











Emergency CS no 
trial of labour  
GESTATION Gestational age at 
delivery 
Integer  Weeks 0-43 
Day 0-7 
SEX Sex of the infant Categorical Male 
Female 
WEIGHT Birthweight in 
grams 
Integer  




score at 1 minute 
and 5 minutes after 
birth  
Integer  






































Appendix iv - Maternal and Infant characteristics IDEAS database codebook 
 
Variable  Description Variable Values 
Mothers name Maternal forename 
and surname 
String Free text 
Partner’s name Partner forename 
and surname 
String Free text (if applicable) 
Due date Estimated date of 
delivery  
Date DD-MM-YYYY 






Gestation at date 
of outcome 
Integer  Weeks 0-43 
Day 0-7 
Reason for delivery Indication for 
delivery 
String Free text 
















Outcome of the 
latest pregnancy  
Categorial Ectopic pregnancy 
Late miscarriage  
Late neonatal death 
Live birth 













identified at birth 
Categorical  Intrauterine Growth 
Restriction  




Gestational age at 
delivery 
Integer  Weeks 0-43 
Day 0-7 
Sex Sex of the infant Categorical Male 
Female 
Weight (g) Birthweight in 
grams 
Integer  






score at 1 minute 
and 3 minutes after 
birth  
Integer  




String Free text 




















Insert a comment (free 
text) 
Date of death Date of death of 




Appendix v - Maternal and Infant characteristics Cork Fertility Centre database 
codebook  
 
Variable  Description Variable Values 
Name Maternal forename and 
surname 
String Free text 
Due date Estimated date of delivery  Date DD-MM-YYYY 
CFC* Cork fertility centre 
medical record number 
Numeric Numeric 
Single/Twin Number of fetuses in this 
pregnancy 
Integer   
Date of delivery Date of delivery  Date DD-MM-YYYY 
Gestational age Gestation at date of 
outcome in weeks and 
days 
Integer  Weeks 0-43 
Day 0-7 










Gestational age at 
delivery 
Integer  Weeks 0-43 
Day 0-7 
Sex Sex of the infant Categorical Male 
Female 







Appendix vi - Screen tests database codebook 
Test Date Result Remarks 
AMH- Pre-Infertility Test DD-MM-YYYY  Free text 
FSH test DD-MM-YYYY  Free text 
Free T4 DD-MM-YYYY  Free text 
LH test DD-MM-YYYY  Free text 
Oestrogen test DD-MM-YYYY  Free text 
Progesterone test DD-MM-YYYY  Free text 
Prolactin DD-MM-YYYY  Free text 
Rubella DD-MM-YYYY  Free text 
T4&TSH DD-MM-YYYY  Free text 





























Appendix viii - Sample of survey 
Sample of survey distributed to women as part of the survey-prospective study of 
women attending for fertility consultation or treatment at Cork Fertility Centre and 
as part of the prospective study of nulliparous women attending for IVF/ICSI 
treatment at Cork Fertility Centre. 
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